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HIV is major public problem in the world and in Sub-Saharan Region in particular. The literature 
has shown that mental disorders and particularly depression are common among people living 
with HIV/AIDS, but that little is known about the prevalence of depression and factors 
associated with it, among people living with HIV/AIDS in Rwanda. 
A descriptive, cross-sectional study was done to assess the prevalence of depression, the clinical 
profile and the factors associated with depression among people living with HIV and attending a 
primary health care centre in Kigali-Rwanda. This study was informed by the stress and 
vulnerability framework. A questionnaire was used to collect socio-demographic and HIV 
related medical information, while depression was assessed using the Beck Depression Inventory 
Scale, with a cut off of less than 10 for no depression and above 10 scoring positive for 
depression. Respondents were randomly selected from the patient appointment list for patients 
who were scheduled during the period of data collection and according to the sample selection 
criteria. The sample consisted of 96 people living with HIV. Permission to conduct the study was 
requested and obtained from the University of Kwazulu-Natal Ethics Committee, from the CNLS 
Research and Ethics Committee in Rwanda and from the management of the health care centre to 
consult patients' files. 
Data was analyzed using the Statistical Package for the Social Sciences (SPSS for window, 15). 
Descriptive data was analyzed by means of frequencies, mean and standard deviation. Cross 
tabulation using Pearson' chi-square test was performed to test the association between socio-
demographic factors and HIV related medical information and depression for categorical 
variables, while t-test for independent simple test was performed for continuous variable. Multi 
logistic regression analysis was performed to test further association between the above 
mentioned factors with depression, while controlling for confounders. The results were presented 
by means of tables, histograms and graphs. 
The findings of the study revealed that depression is very high among HIV-infected patients 
attending a primary health care centre in Kigali, with a prevalence of 41.7%. The most frequent 
depressive symptoms presented were pessimism, fatigability, sad mood; lack of satisfaction, 
somatic preoccupation, loss of libido, crying spells, work inhibition, irritability, social 
v 
withdrawal and loss of appetite. The majority of respondents scored mild to moderate 
depression, whereas few had moderate to severe depression and only very few scored severe 
depression. Having considered all other socio-demographic and HIV related medical factors that 
were studied, being a female, having presented many HIV-related symptoms in the month prior 
to data collection, and having less than 250 CD4 counts were statistically associated with 
depression. On the other hand, having high social and family support was a protector factor to 
depression. 
Although the results of this study are not generalizable to the Rwandan population living with 
HIV, they underscore the importance of integrating mental health in HIV/AIDS services for the 
care of those who present mental problems related to HIV such as depression. 
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Introduction to the Study 
1.1 Background to the study 
HIV/AIDS continues to be a major public health problem worldwide. The Joint United 
Nations Programme on HIV/AIDS [UNAIDS], 2008) estimated that in 2007, 33 million 
people were living with HIV/AIDS, 2.7 million people were newly infected with the 
virus and 2 million people died due to AIDS related illnesses. 
Sub-Saharan Africa is one of the world regions most affected by HIV/AIDS. The region 
comprises nearly fifty sovereign countries grouped into five sub-regions, namely Eastern 
Africa, Southern Africa, West Africa, Central Africa and the islands of the eastern coast 
of the continent (Beaglehole et al., 2008). The World Bank defines the majority of the 
countries within the region as middle-income to low-income countries. The region has a 
population of approximately 809115,000, 2.7% (22 million) of whom are living with 
HTV/AIDS (Population Reference Bureau, 2008). According to the UNAIDS report, 
67% of all the people living with HIV/AIDS world-wide live in this region. This same 
report indicates that for 2007, 17 million people were newly infected with HIV and that 
75% of all AIDS related deaths world-wide occurred in this region (UNAIDS, 2008). 
The HIV/AIDS prevalence for adults in this region varies substantially from sub-region 
to sub-region and from country to country, ranging from 23-32% in Botswana and 
Swaziland, 12-28% in South Africa and to between 2% to 5% in many East African 
countries (UNAIDS, 2008). The HIV/AIDS adult prevalence has decreased in a number 
of East African countries and most notably in Rwanda from 5.2 % in 2004 to 3% in 2008 
(UNAIDS, 2008). The prevalence of HIV/AIDS varies in Rwanda from 7.3% in urban 
areas to 2.2% in rural areas (UNAIDS, 2008). 
Although the HIV/AIDS overall prevalence rate is decreasing in parts of the sub-Saharan 
region it is the leading cause of death in the region and fourth in the list of the ten leading 
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diseases for global disease burden (Stuckler, King, Robinson & McKee, 2008). 
Furthermore, HIV/AIDS is increasingly regarded as a chronic disease which in turn, 
contributes to the burden of chronic diseases which is increasing in low-income and 
middle-income countries (Beaglehole et al., 2008). 
While HIV/AIDS dominates the overall burden of fatal diseases, neuropsychiatric 
conditions and particularly depression is responsible for the greatest proportion of the 
global disease burden for the non-fatal disabling conditions (Lopez, Mathers, Ezzati, 
Jamison & Murray, 2006). Depression is the seventh leading cause of burden of disease 
in low-middle income countries and the third leading cause in high income countries. 
Beaglehole, et al. (2008), estimate that neuropsychiatric disorders, most notably uni-polar 
depression, account for 14% of the global burden of disease. These authors demonstrate 
that this figure is increasing, particularly in lower-middle income countries. 
The World Health Organization [WHO] Report on HIV/AIDS and mental health outline a 
number of studies which have demonstrated a high prevalence of psychiatric disorders in 
people infected by HIV/AIDS (WHO, 2008). According to Faber and McDaniel (2002) 
the prevalence rates of psychiatric disorders among people living with HIV are high, but 
vary from country to country and from study to study. Bing, Burnam and Longshore 
(2001) conducted a study to estimate the prevalence of psychiatric disorders and 
substance abuse among American adults infected by HIV and found that nearly half of 
their sample («=2864) reported a psychiatric disorder. Similarly, Israelski et al. (2007) 
estimated the prevalence of psychiatric co-morbidity among a group of people in 
Northern California receiving primary care for HIV/AIDS. This study revealed that in a 
sample of 118 people, 56% screened positive for at least one psychiatric disorder. 
A number of studies conducted in different countries in Africa, have documented a high 
prevalence of psychiatric disorders among people with HIV/AIDS (Adewuya et al., 2007; 
Myer et al. 2008; Sebit et al., 2003). These rates range from 19% (South Africa), 59% 
(Nigeria), and 71% (Zimbabwe) to 81% (Uganda). This variation in rate may be related 
to either clinical aspects such as HIV disease stage, or the methodology used to determine 
this prevalence. For example Myer et al. (2008) studied the common mental disorders 
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among individuals living with HIV in South Africa. This study found the overall 
prevalence of mental illness in HIV-infected individual to be high, with 19% of 
participants having either depression, post traumatic stress disorder, or alcohol 
abuse/dependence. In Nigeria, Adewuya et al. (2007) found that 59% of HIV-positive 
individuals who participated in their study had a co-morbid psychiatric disorder, and this 
rate was significantly higher than in non infected patients. In Zimbabwe, psychiatric 
disorders were also found to be high among people living with HIV/AIDS. The findings 
showed that 71.3% of HIV infected individuals had a co-morbid psychiatric disorder, 
compared to 44.3% of the HIV negative control group (Sebit et al., 2003). In Uganda, 
Petrushkin, Boardman and Ovuga (2005) found that the total prevalence of psychiatric 
disorders was 82.6% of which depressive and anxiety disorders were the most common. 
A number of reasons are given for the presence of psychiatric disorders among people 
living with HIV/AIDS. Freeman, Patel, Collins, and Bertolote (2005) state that pre-
morbid mental history, the effects of the HIV virus on the central nervous system, the 
psychological impact of living with HIV/AIDS, side effects of medication and results of 
social stigma and discrimination constitute some of the reasons for the high level of 
mental disorders affecting people living with HIV/AIDS. However, according to 
Freeman, Nkomo, Kaffaar and Kelly (2007), not everyone living with HIV/AIDS has a 
mental disorder. 
Research suggests there are some socio-demographic factors and HIV medical related 
factors that increase the risk of having depression among people living with HIV/AIDS. 
Clinical factors such as number of HIV related symptoms, short time since the HIV status 
is known, illicit drug use and heavy alcohol use were significantly associated with 
psychiatric disorders among people living with HIV/AIDS (Bing et al., 2001; Myer et al., 
2008). On the other hand, socio-demographic factors such as unemployment, marital 
status, living alone and poor social support were found to be significantly associated with 
the high prevalence of psychiatric disorders among people living HIV/AIDS (Adewuya et 
al., 2007; Bing etal , 2001). 
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Depression has been found to be the most common psychiatric disorder affecting people 
with HIV/AIDS. According to Valente (2003), depression constitutes one of the most 
common reasons for psychological evaluation and treatment for people living with HIV 
infection. It is estimated that a prevalence of depression among people living with 
HIV/AIDS in industrialized countries range from 9 to 60% (Kaharuza et al., 2006). Two 
studies, HIV Costs and Service Utilization Study (HCUS) and the Coping with 
HIV/AIDS in the Southeast Study (CHASE) (cited in Whetten, Reif, Whetten & Murphy-
McMillan, 2008) found that depression was the most prevalent psychiatric disorder 
among people living with HIV in the United States, with similar lever of prevalence rate 
of 36% and 35% respectively. Basu, Chwastiak, and Bruce (2005) report that the 
prevalence of psychiatric disorders among HIV infected people in India is approximately 
50% with major depressive disorder being the most common co-morbid disorder with a 
prevalence ranging from 4% to 45%. In Uganda, Kaharuza et al. (2006) found that among 
1017 HIV-infected participants assessed for depression, 47% screened positive for 
depressive symptoms. 
Although psychiatric disorders, particularly depression, appear to be high in people living 
with HIV/AIDS they frequently go undetected and therefore untreated in HIV care 
settings (Israelski et al., 2007; Petrushkin et al., 2005). For example, Israelski et al. 
(2007) found that 56% of participants met symptom criteria of depression, post traumatic 
stress disorders and acute disorders, and of these, 43% reported no current treatment for 
any mental health condition. Only 24% of participants reported currently receiving 
psychotherapy services, and only 35% reported current use of psychiatric medications. 
Similarly, Petrushkin et al. (2005) found that among a small sample of 46 participants 
attending an urban clinic in Uganda, 38 screened positive for depressive and anxiety 
disorders, but none were receiving any treatment for their psychiatric disorders. 
Untreated depression among HIV infected people has been found to be associated with 
poor outcome of HIV/AIDS treatment and is likely to cause immunosuppression 
(Olatunji, Mimiaga, O'Cleirigh & Safren, 2006). Berger-Greenstein et al. (2007) found 
that some of the symptoms of depression such as difficulty concentrating, fatigue and 
suicidal thoughts interfere with medication adherence among people with HIV. 
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It is argued that there can be no health without mental health and that systematically 
addressing neuropsychiatric disorders in primary health care is one of the ways in which 
the burden of co-morbid diseases, especially mental disorders and HIV/AIDS, can be 
reduced over time (Prince et al., 2007). Depression has been found to be associated with 
lower overall health and poorer quality of life among people living with HIV/AIDS than 
with HIV-negative control groups (Williams et al., 2005). The degree of psychological 
distress is frequently related to the severity of symptoms of HIV infection, to a shortened 
life-expectancy, to complicated therapeutic regimens, stigmatization and loss of social 
support. Studies on the treatment of depression in people living with HIV/AIDS have 
showed promising results. In a critical review on the treatment of depression in people 
living with HIV/AIDS, antidepressant medications were shown to be as effective in 
ameliorating major depression in HIV-positive patients as in physically healthy patients 
(Ferrando & Freyberg, 2008). On the other hand, psychological interventions combining 
cognitive-behavioral therapy, individual psychotherapy, counseling, and education on 
self-management techniques have been shown to effectively treat depression in people 
living with HIV/AIDS (Valente, 2003). 
Rwanda has made a number of efforts to improve the medical care of those affected by 
HIV/AIDS and it is more than likely that these efforts have contributed to the decreasing 
adult prevalence rate. For example, services for the prevention of HIV transmission from 
mothers to children have expanded and are accessible in more than half of the country's 
health facilities. Furthermore, the rate of male partners participating in mother to child 
transmission prevention services has increased from 9% in 2003 to 74% in 2006 
(UNAIDS, 2008). The sites providing ARVs increased from 76 in 2005 to 165 in 2007, 
and the ARVs coverage rate from 71% to 84% (UNAIDS, 2008). 
The World Health Organization (WHO, 2008) recommends that a successful HIV/AIDS 
intervention programme should include appropriate strategies for the assessment and 
management of mental disorders as part of the routine service. Israelski et al. (2007) and 
Freeman et al. (2005) argue that people receiving primary care for HIV/AIDS should be 
routinely screened and treated for symptoms of mental disorders as this has been shown 
to significantly improve the HIV disease outcome. These authors suggest that estimating 
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the prevalence of depression among HIV/AIDS affected people is important to 
developing and/or improving services for the treatment of mental illness at HIV treatment 
sites and thus, to improving HIV disease outcome and quality of life. 
1.2 Problem statement 
Although the impact of depression on quality of life in HIV/AIDS affected people is 
reasonably well documented in developed and high income countries, there are limited 
studies of the prevalence of depression in primary care HIV/AIDS treatment settings in 
Rwanda. However, statistical data provided by services delivering psychosocial care to 
people living with HIV/AIDS in Rwanda estimate that psychiatric disorders are common 
in HIV infected patients. The statistics of Women Equity in Access to Care and 
Treatment (WE-ACTx) show that of the 2640 HIV/AIDS people enrolled with the 
programme and attending for psychological follow-up, 49% experienced depression and 
41% had a post traumatic stress disorder (Uwineza, Fabri, Zaninyana & Mafurebo, 2008). 
The Treatment and Research AIDS Center [TRAC], 2008) recognizes that psychosocial 
care is an important component of a successful HIV service, and appears in the Rwanda 
National strategic plan for HIV and AIDS 2009-2012 as care and support outside the 
medical treatment. One of the strategies to achieve this is to integrate psychosocial 
support and mental health in the routine follow-up of the HIV patients (Commission 
Nationale de Lutte Contre le Sida [CNLS], 2009). Prince et al. (2007) argue that HIV 
services would be more likely to offer routine mental health care if the connection 
between depression and HIV/AIDS and between physical disorders and mental health in 
general, were better understood and appreciated. 
This study therefore focuses on the prevalence of depression among HIV infected people 
attending an urban Primary Health Care Centre in Kigali, Rwanda It will also explore the 
possible associations between depressive symptoms, socio-demographic factors and 
selected HIV medical related indicators. 
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1.3 Purpose of the study 
The purpose of this study is to explore the prevalence of depression and to analyze the 
factors associated with depression among HIV infected patients attending the Kimironko 
Health Centre. 
1.4 Research objectives 
1.4.1 To explore the prevalence of depression among HIV infected patients 
attending the Kimironko Health Centre. 
1.4.2 To describe the clinical profile of depression among HIV infected patients. 
1.4.3 To explore the relationship between socio-demographic factors (age, gender, 
marital status, employment, socioeconomic status, social support, and history 
of a psychiatric disorders) and depression in people living with HIV/ AIDS. 
1.4.4 To explore the relationship between HIV medical related indicators (CD4 cell 
counts, HIV related symptoms and time known of HIV status) and depression 
in people living with HIV/AIDS 
1.5 Research questions 
1.5.1 What is the rate of depression among HIV infected patients attending 
Kimironko Health centre? 
1.5.2 What depression symptoms constitute depression among people living with 
HIV/AIDS? 
1.5.3 What is the relationship between socio-demographic variables and depression 
among people living with HIV/AIDS? 
1.5.4 What is the relationship between HIV related indicators and depression among 
people living with HIV/AIDS? 
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1.6 Significance of the study 
The World Health Organisation report on HIV/AIDS and mental illness (WHO, 2008) 
has indicated that while low and middle-income countries carry more than 90% of the 
burden of HIV/AIDS, there is very little information about the interaction between 
HIV/AIDS and mental health in these countries. 
The findings of this study would add to the limited body of knowledge about the 
prevalence rate of depression among HIV/AIDS infected patients in Rwanda. This will 
serve as a clinical reference to HIV care providers who may use the findings of this study 
to offer comprehensive care to their patients living with HIV/AIDS. 
Since little is known about the prevalence of depression and the factors associated with 
depression in a population of people living with HIV in Rwanda, this study might serve 
as a foundation for future public health and nursing research in the area, thus deepening 
understanding of the issue. It is therefore anticipated that the study findings will 
contribute to the development of local knowledge about mental illness and HIV/AIDS 
and be used to informed nursing education curricula for both community and mental 
health nursing. The findings of this study might also help in influencing the development 
of appropriate policies, plans and intervention programmes for the management and 
treatment of psychiatric illnesses in HIV/AIDS treatment settings. This in turn, might 
improve the quality of care for people with HIV/AIDS who are also suffering from 
depression and thus and in so doing, their quality of life. 
1.7 Definition of key concepts 
1.7.1 People living with HIV/AIDS 
People living with HIV/AIDS are defined in this study as all adults (18 years and older) 
who have been tested positive for HIV and who are receiving care and treatment at 
Kimironko Health Centre. 
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1.7.2 Depression 
In this study, depression will be defined from the score obtained in Beck Depression 
Inventory Scale. All people living with HIV/AIDS who will have a score greater thanlO 
in the 21 Beck Depression Inventory will be considered as having depression. 
1.7.3 Prevalence 
In this study, prevalence refers to the extent to which depression is common in a sample 
of people living with HIV/AIDS and attending a primary health care center. 
1.7.4 A primary health care center 
A primary health care center is a health care center which offers comprehensive care to 
patients and which has an HIV/AIDS care and treatment service. 
1.8 Conceptual framework 
The conceptual framework for this study has been drawn from the literature on 
HIV/AIDS and psychiatric disorders, as well as from aspects of the stress vulnerability 
model of illness development (Adewuya et al., 2007; Berger-Greenstein et al., 2007; Bing 
et al., 2001; Farber & McDaniel, 2002; Komiti et al., 2003; Uys & Middleton, 2004). 
According to Farber and McDaniel (2002), HIV/AIDS poses a number of acute and 
ongoing challenges that may influence emotional distress levels and psychiatric co-
morbidity. Aspects of the stress vulnerability model of chronic and mental illness explain 
the impact of these challenges on this co-morbidity. This model suggests that biological 
factors predispose individuals to developing emotional problems and or/ specific 
diagnosable psychiatric symptoms in the presence and action of a number of personal and 
social factors. The psychiatric rehabilitation literature conceptualizes psychiatric 
symptoms as impairments. The term psychiatric symptoms will be retained for this study. 
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These factors may be both source of stress and a source of protection, depending upon 
their presence and action (Uys & Middleton, 2004). 
To establish the key variables for this conceptual framework, a variable table was 
developed from eleven studies related to the prevalence of psychiatric disorders and 
depression among people living with HIV/AIDS. The variables studied, the tools used to 
collect data for each variable and the statistical tests applied to determine the relationship 
between these variables is outlined in Appendix 5. The most common variables 
associated with each of the factors for this study are schematically presented in diagram 
1. In this study, HIV related disease factors constitute biological factors; specific socio-
demographic factors such as gender, marital status, social support, employment, social 
economic status are defined as social and personal factors and depression the outcome of 
the interaction between these factors. However, as Freeman et al. (2007) state, not 
everyone living with HIV/AIDS has a mental disorder. 
The diagram shows, according to the stress vulnerability framework, how these factors 
might be related. The more biologically compromised the individual (low CD4 Count, 
progression towards AIDS, high viral load), and the less the presence and action of 
protective personal and social factors, the more likely the person is to developing serious 
depressive symptoms. Likewise, the more biologically compromised the individual (low 
CD4 Count, progression towards AIDS, high viral load), and the greater the presence and 
action of protective personal and social factors, the less likely the person is to developing 
serious depressive symptoms. (Adewuya et al., 2007; Berger-Greenstein et al., 2007; 
Bing et al., 2001; Farber & McDaniel, 2002; Kaharuza et al., 2006; Komiti et al. 2003; 
Leserman et al., 2000; Uys & Middleton, 2004). 
• 
Socio-demographic factors found to be associated with the presence and severity of 
depressive symptoms among people living with HIV/AIDS include the marital status, 
unemployment and lack of social support; past contact with mental health service due to 
pre-morbid psychiatric illness; gender where women are more likely to suffer depression 
and anxiety disorders than men; age, where younger age people with HIV/AIDS are more 
likely to suffer with a psychiatric disorders than those 50 years and older; and poor social 
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economic status (Bing et al., 2001; Komiti et al., 2003). Compared to non-depressed 
participants in a study by Komiti et al. (2003), the depressed participants were less likely 
to secure a paid full time employment and were more likely to be involved in stable 
intimate relationship or living with one's partner. 
Diagram 1: Schematic Representation of the Conceptual Framework 
(Adapted from Adewuya et al. 2007; Farber & McDaniel, 2002; 
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HIV medical related factors indicate biological vulnerability. A number of studies have 
found that specific HIV related factors such as the progression of HIV towards AIDS, 
low CD4 cell counts or advanced clinical stage of AIDS illness; short time since the HIV 
status is known; patients who are not on ART; are associated with an increase in the 
presence and the severity of depressive symptoms (Berger-Greenstein et al., 2007; Bing 
et al., 2001; Freeman et al. 2007; Judd et al., 2005; Komiti et al., 2003). 
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1.9 Conclusion 
The aim of this chapter was to highlight the background to the problem of mental health 
problems encountered among people living with HIV/AIDS, drawing both from 
international and African literature. The aim, objectives, research questions and 
conceptual framework have been presented and discussed. This next chapter will explore 





This chapter reviews some of the current literature with respect to the phenomenon of 
depression and its prevalence among people living with HIV/AIDS. The following search 
terms "Psychiatric disorders and HIV/AIDS, mental disorders in HIV/AIDS, depression 
among people living HIV/AIDS" were use to search for literature in the on-line databases 
of CINAHL, MEDLINE-EbscoHost, MEDLINE-PubMed, Cochrane library, BioMed 
Central, Science Direct, and LWW Journals @ OVID full text. 
The literature review is presented in three sections. The first section provides an overview 
of epidemiological trends of HIV/AIDS globally, within the sub-Saharan Africa continent 
and within Rwanda. It also highlights the available literature on prevalence of depression 
in the Rwandan population. The second section reviews common psychiatric disorders 
affecting people living with HIV/AIDS while the third section explores depression 
among HIV infected patients, and its impact in the evolution and treatment outcomes of 
HIV/AIDS. Thereafter, the role of the mental health nurse in the management of mental 
health problems associated with HIV/AIDS is briefly discussed. 
2.2 HIV/ AIDS and Mental Illness in Rwanda 
2.2.1 HIV/AIDS in Rwanda 
Rwanda is a small, landlocked country (approximately 228.200 square kilometers) 
located in East Africa, bordered by the Democratic Republic of Congo in the East, 
Burundi in the South, Tanzania in the West and Uganda in the North. It is considered the 
most densely populated country in Africa, with an estimated population of 9.200.000 and 
a population density of 351 persons per square Km (CNLS, 2009). Rwanda is designated 
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a low income category country according to the World Bank classification of countries 
(http://web.worldbank.org). 
The first case of HIV/AIDS in Rwanda was discovered in 1983 in the "Centre Hospitalier 
Universitaire de Kigali". The first study on HIV prevalence among the general population 
in Rwanda was carried out in 1986. This study established a prevalence rate of 17.8% in 
urban settings and 1.3% in rural areas (CNLS, 2007). At the end of 2001, it was estimated 
that 11.1% of the adult population in Rwanda were living with HIV/AIDS (UNAIDS, 
2002). 
This rate has steadily declined to 7% in 2004 and to 3% among the general population in 
2005 (CNLS, 2007; UNAIDS, 2008). This decline in prevalence is possibly associated 
with the coordinated efforts of the Ministry of Health, TRAC Plus and the District Aids 
Control Committee which are available in each of the 30 districts of the country (CNLS, 
2009). These efforts have focused on increasing the number of sites providing 
antiretroviral therapies and implementing the five key treatment strategies contained 
within the Rwandan AIDS National Care and Treatment Plan 2003-2007 (Ministry Of 
Health [MOH], 2003). These treatment strategies emphasize making medical treatment 
available, increasing adherence, providing psychosocial care in the form of group 
counseling and community based support, initiating community and home base care and 
giving support in terms of assistance required for the success of medical treatment 
(MOH, 2003). In line with this plan, the number of sites for antiretroviral therapy has 
increased from 76 in 2005 to 165 in 2007 thus enabling 65% of the population requiring 
ARVs to access treatment (MOH, 2007). Currently, there are 313 Voluntary Counseling 
and Testing sites and 285 sites for Protection of Mother -To- Child Transmission (MHO, 
2007). 
2.2.2 Mental health in Rwanda 
Mental health in Rwanda is coordinated by the national mental health programme in the 
Ministry of Health, and mental health care services have been integrated into primary 
health care system. With 0.2 total psychiatric beds per 100.000 population, the country is 
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served by 0.03 psychiatrists, 0.8 psychiatric nurses and 0.3 psychologists per 100.000 
populations (WHO Atlass. 2005). 
There is very limited research available in the literature on the epidemiology of mental 
disorders in Rwanda. There are a few studies about the effects of the Rwandan genocide 
on mental health of children and adolescents (Dyregtov, Gupta, Gjestad & Mukanoheri, 
2000; Schaal & Elbert, 2006) and the mental health needs of refugees (De Jong, Scholte, 
Koeter & Hart, 2000). Dyregtov et al. (2000) assessed the trauma exposure and 
psychological reactions to genocide among Rwandan children approximately a year after 
the genocide and concluded that 79% of the interviewed children presented moderate to 
severe post traumatic stress reactions. 
Approximately ten years after the genocide, Schaal and Elbert (2006) conducted a study 
to assess the post traumatic reactions among orphans in Rwanda. This study found that 
among 68 orphans interviewed, 44% met the full DSM-IV criteria for PTSD. A study of 
trauma and post traumatic stress symptoms among adults Rwandan found that of the 
2091 participants, 518 (24.8%) met symptoms criteria for PTSD (Pham, Weinstein & 
Longman, 2004). In a survey conducted by de Jong et al. (2000) to assess the prevalence 
of mental health problems in Rwandan and Burundese refugee camps, it was estimated 
that 50% (n=854) of adults who were living in these refugee camps suffered severe 
mental disorders. 
2.2.3 Depression in Rwanda 
Although there is not much information available in the literature regarding the 
prevalence of depression in the general population in Rwanda, a few studies assessing 
depression showed it to be high both in HIV-infected and among the genocide affected 
group. Cohen et al. (2009) conducted a study to assess the improvement in the post 
traumatic stress and depressive symptoms in HIV-infected Rwandan women on 
antiretroviral therapy, and found that at baseline, 59% of HIV positive women (n=779) 
had post traumatic stress, while 81% of them had clinical significant depression. 
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Studies assessing depression following the 1994 genocide have shown it to be high 
among the affected groups. Bolton, Neugebauer and Ndogoni (2002) conducted a 
community-based survey in a selected rural area five years after the 1994 genocide and 
found a prevalence rate of 15.5% for depression among a sample of 368 adult Rwandans 
living in this area. 
Similarly, Hangengimana, Hinton, Bird, Pollack and Pitman (2003) conducted a study to 
determine the rate of panic attacks, panic disorders, post traumatic disorders and 
depression levels in a population of Rwandans survivors of 1994 genocide using Beck 
Depression Inventory Scale and additional scales. The findings of the study reported that 
in a sample of 100 Rwandans women survivors of the 1994 genocide, 35% presented 
with symptoms of panic disorders, 18.6% scored positive to depression on BDI and 
62.3% presented post traumatic stress disorders symptoms on Harvard Trauma 
Questionnaire. 
A more recent cross-sectional survey conducted by Boris et al. (2008) examined the level 
of depressive symptoms and their predictors in youth heads of household from one 
selected region in Rwanda. This study used the Centre for Epidemiologic Studies 
Depression Scale. The findings revealed that 53% of their sample (n: 539) screened 
positive for depression. This same study found that predictors such as eating fewer than 
one meal per day, having three household assets or fewer, youth with fair or poor health, 
not having a close friend, having a parent who died during the genocide, and high levels 
of grief were significantly associated with depressive symptoms. 
2.3 Psychiatric disorders in people living with HIV/AIDS 
Like any other chronic and fatal disease, HIV/AIDS affects every aspect of a person's 
life, including their mental health. Many research studies suggest that mental illnesses are 
common in people living with HIV (Bing et al., 2001; Morrison et al., 2002; WHO, 
2008). Bing et al. (2001) conducted a study to estimate the prevalence of psychiatric 
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disorders and substance abuse among American adults infected by HIV and found that 
nearly half of their sample (n=2864) reported a psychiatric disorders, namely major 
depression, anxiety disorders such as general anxiety disorder and panic attack, and 40% 
reported having used an illicit drug. Similarly, Israelski et al. (2007) estimated the 
prevalence of psychiatric co-morbidity of three stress related disorders, namely 
depression, post traumatic stress disorders and acute stress disorders among Northern 
Californians receiving primary care for HIV/AIDS. Their study revealed that in a sample 
of 118 people, 56% screened positive for at least one psychiatric disorder. Vitiello, 
Burnam, Bing, Beckman and Shapiro (2006) found that 29.1% of all patients studied in 
the United States (n=2864) met criteria for at least one of the studied psychiatric 
disorders namely major depression, dysthymia, generalized anxiety disorder, panic 
disorders and PTSD. 
The prevalence of mental disorders in people living with HIV/AIDS in South Africa 
ranges from 19% to 43.7%. For example, Freeman et al. (2007) estimated the prevalence 
of mental disorders in this population using a large sample (n=900). This study found that 
43.7% of the total sample screened positive to at least one mental disorder. The most 
common disorders in this study were depression, alcohol abuse and post traumatic stress 
disorders. Myer et al. (2008) studied three common mental disorders (depression, post 
traumatic stress disorder and alcohol dependence/abuse) among individuals living with 
HIV/AIDS and found that 19% of their sample (n=88) met criteria for at least one 
psychiatric disorder. 
Four of the most commonly occurring psychiatric problems in people living with 
HIV/AIDS are mood disorders, suicide, anxiety disorders and substance abuse and these 
are reviewed below. 
2.3.1 HIV/AIDS and mood disorders 
Mood disorders commonly studied among people living with HIV include major 
depression, bipolar disorder and dysthymia (Bing et al., 2001; Israelski et al., 2007; 
Morrisson et al., 2002). Of all the mood disorders, major depression has been found to be 
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the most common disorder affecting people living with HIV (Berger-Greenstein et al., 
2007). These authors found that in a sample of 85 patients, 72.9% screened positive for 
major depressive disorders, 14.1% of participants screened positive for bipolar disorder, 
and 4.8% for dysthymia. 
A number of studies suggest that the prevalence rates for depression among HIV/AIDS 
infected people are in general high, both in high income and middle to low income 
countries (Collins, Holman, Freeman & Patel, 2006). Two studies conducted in the 
United States, namely the HIV Cost Service Utilization Study (Bing et al., 2001) and the 
Coping with HIV/AIDS in the Southeast (Pence et al., 2007) found that depression was 
the most prevalent psychiatric disorder among people living with HIV. Bing et al. (2001) 
used a nationally representative cohort of the HIV Cost Service Utilization Study 
(n=2864) and found that more than one third of the population study (36%) met the 
criteria for major depression, and 26.5% screened positive to dysthymia. Similarly, Pence 
et al. (2007) studied 611 patients living with HIV in the Southeast America and found 
that around 35% of the participants scored positive to depression, and 16% met criteria 
for post traumatic stress disorder. This prevalence rate is similar to that reported by 
Israelski et al. (2007) who found that among 350 patients, 80 participants (38.1%) 
screened positive for depression. 
The prevalence rates of depression among HIV infected patients in America seem to be 
greater than the overall prevalence of major depressive disorders in the general American 
population. This has been estimated to be 9.50 % in a national representative sample 
(n=8449) (Riolo, Nguyen, Greden & King, 2005). A more recent study involving a 
sample of 9090 found a 16.2% life-time prevalence of major depression in the general 
American population and a 6.6% prevalence for 12 months (Kessler et al., 2007). 
In Australia, depressive disorders among HIV infected patients have been also found high 
in a study by Judd et al. (2005) conducted to understand the nature of depression among 
129 HIV infected patients attending a primary care setting. The findings report a high rate 
of depressive disorders, where 27% of the participants met the criteria for a mood 
disorder. Similarly, Kolaric, Tesic, Ivankovic and Begovac (2006) assessed the 
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prevalence of depression among Croatians HIV-infected patients and found that 20% of 
their sample screened positive to moderate and severe depression. 
In a systematic review of studies done in different low and middle income countries 
Collins et al. (2006) found that the average rate of depression among HIV asymptomatic 
patients in these countries was between 6%, ranging from 0% in Democratic Republic of 
Congo to 10.9 % in Brazil and as high as 4.4% to 19.6% among symptomatic patients in 
these same respective countries. Myer et al. (2008) studied three common mental 
disorders namely depression, post traumatic stress disorders and alcohol abuse among 
people living with HIV in South Africa and found a prevalence rate of 14%, 5% and 7% 
respectively. Freeman et al. (2007) studied the prevalence of mental disorders among 
HIV infected patients and found that the main diagnosis was depression, with an estimate 
of 11% for major depression and 29.1% for minor depression. Other mental disorders 
found by these authors were alcohol abuse disorders (12.9%), alcohol dependence 
(2.9%), post traumatic stress disorders (4.2%) and intermittent explosive disorders 
(3.9%). Another study conducted in South Africa targeting the most recently diagnosed 
HIV patients attending an outpatient clinic found that major depression was as high as 
35% among this population (Olley, Seedat & Stein, 2006). 
However, the prevalence of depression among people living with HIV in South Africa, an 
upper- middle income country, is higher than the estimated prevalence of depression in 
the general population. In an epidemiological study of major depression in South Africa, 
it was found that the prevalence of major depression in general population was 9.7% for 
lifetime prevalence and 4.9% for the 12 months prior to interview (Tomlinson, Grimsrud, 
Stein, Williams & Myer, 2009). 
In Uganda, Kaharuza et al. (2006) found that among 1017 HIV infected patients who 
were assessed for depression using the Center for Epidemiologic Studies Depression 
Scale, 476 (47%) reported depressive symptoms. A prevalence rate close to this was also 
found by Ndetei et al. (2009) who conducted a cross-sectional study to determine the 
prevalence of psychiatric disorders among HIV infected patients in Kenya. This study 
found that overall, 42.3% of the total sample screened positive depression using BDI, 
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whereas in Nigeria, major depression was the highest affective disorders (11.4%) among 
HIV infected patients, followed by dysthymia (9.1%), hypomania (6.8%) and mania 
(3.4%). 
High rates of depression have been also found among people diagnosed with other 
chronic medical conditions such as chronic hepatitis C, cardiovascular diseases, diabetes 
(Kagee, 2008; Zhang, Ye, Huang, Li, & Yang, 2008). Zhang et al. (2008) assessed the 
level of depression among patients with cardiovascular disease, diabetes, and chronic 
pulmonary heart disease and found high rate of 78.9% of patients with the above 
mentioned chronic diseases having different levels of depression (n=322). In the same 
way, Kagee (2008) in South Africa conducted a study to estimate the prevalence of 
depression and anxiety among south African patients living with a chronic illness and 
found that 26.1% had mild to moderate depression, 15.3% had moderate depression and 
4.5% had severe depression, whereas 38.5 % of the total sample (n=l 19) scored elevated 
range of anxiety. 
Depression was also high among patients treated for chronic hepatitis C. Before 
treatment, 11% of patients had mild depression, but when depression was again assessed 
during treatment, 55% developed depression (Fransen Van de Putte, Fischer, Posthouwer, 
Van Erpecum & Mauser-Bunschoter, 2009). Similarly, in a study by Arnold et al. (2008) 
regarding the prevalence of depression and anxiety among patients with primary brain 
tumor, it was found that 41% had current depression and 48% had current generalized 
anxiety disorders. Only 5% of this study population had previous diagnosis of a 
psychiatric illness. 
2.3.2 Suicide among people living with HIV/AIDS 
Suicide and suicidal attempts have been found to be high in people infected by 
HrV/AIDS. Komiti et al. (2001) conducted a review of existing literature on suicidal 
behavior in people living with HIV/AIDS and found an increase in both suicidal ideation, 
behavior and completed suicide. Roy (2003) researched the prevalence of suicide among 
people living with HIV and examined the risk characteristics of these patients. In a 
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sample of 149 HIV infected patients, it was found that 66 patients (44.3%) had attempted 
suicide. Gender was related to the increase in suicide attempts, with women being at 
higher risk (p=0.01) than men. Other characteristics associated with suicide attempts 
among people living with HIV in Roy's study was the history of depressive disorders (59 
of 66) with patients who were receiving antidepressant medication being more likely to 
attempt suicide (49 of 66) and a family history of suicide attempt or behavior (17 of 66) 
(Roy, 2003). In France, suicide attempts have been found high among people living with 
HIV/AIDS. Preau et al. (2008) conducted a study with 2932 French people living with 
HIV. The findings indicated that 22% had attempted suicide, a figure which is much 
higher than the prevalence of suicide attempts in the adult French general population of 
8%. 
The literature suggests there are at least three periods in the illness cycle during which 
time people are more at risk for suicide. Meel (2006) argues that the period following the 
person's awareness of HIV status is one of the most important and immediate risk periods 
for suicide. The author suggests that this may be exacerbated by an unexpected positive 
result or a result disclosure for which the person was not adequately prepared beforehand. 
Stolar et al. (as cited in Citron, Brouillette & Becket, 2005) suggest that people infected 
by HIV are at higher risk for suicide in the early course of HIV disease when they are 
adjusting to the diagnosis, and again late in the disease, when the physical burden of 
AIDS becomes severe. 
The prevalence of suicide among people living with HIV was found consistent with 
findings of suicide rate in other medically ill people (Komiti et al., 2001). Misono, Weiss, 
Farm, Redman & Yueh, (2008) conducted a study to assess the incidence of suicide 
among people diagnosed with cancer in the United States. The findings of the study 
revealed that a total of 5,838 suicides were identified among 3.594.750 people with 
cancer, giving an age, sex and race adjusted suicide rate of 31.4 per 100.000 persons, 
which is approximately twice the prevalence rate of suicide in the general American 
population ( 16.7 per 100.000 persons per year suicide rate). 
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Kendal (2007) also conducted a gender comparative study on suicide among people 
diagnosed with cancer in Ontario, using 1.3 million cancer cases and found that a total of 
1572 cases of suicide were enumerated, counting 265 cases of female (0.04%) and 1307 
(0.19%) suicide cases for males. Based on types of cancer, head and neck cancer were 
associated with high rate of suicide in both studies (Kendal, 2007; Misono et al., 2008) 
plus lung and stomach cancer (Misono et al., 2008). 
2.3.3 HIV/ AIDS and anxiety disorders 
Anxiety disorders commonly associated with HIV/AIDS found in the literature include 
generalized anxiety disorder, acute stress disorder, post traumatic stress disorder, panic 
disorder and specific phobia (Bing et al., 2001; Israelski et al., 2007; Morrison et al., 
2002; Olley et al., 2006). Israelski et al. (2007) found that 43.3% of their sample screened 
positive for acute stress disorders, and 33.8% reported having post stress traumatic 
disorders. Berger-Greenstein et al. (2007) found that post traumatic stress disorder was as 
high as 43.5% in a sample of HIV infected patients attending a rural medical service, 
15.3% had panic disorder and 3.6% screened positive to generalized anxiety disorder. 
Similarly, Bing et al. (2001) found that in a sample of 2864 American adult living with 
HIV, 15.8 % met the criteria of generalized anxiety disorder, and 10.5% screened 
positive to panic attack. 
Morrison et al. (2002) estimated that women infected with HIV/AIDS presented high rate 
of all types of anxiety disorders, with estimated rate of 5.4% of social phobia, 3.2 % of 
post traumatic stress disorders, 2.2% of special phobia and generalized anxiety disorders, 
1.1 % of obsessive compulsive disorder and agoraphobia. More than half of the sample 
(n=75) in a study by Safren, Gershuny and Hendriksen (2003) met the criteria for a 
diagnostic of post traumatic stress disorder related to being diagnosed and living with 
HIV/AIDS. The Coping with HIV/AIDS in the Southeast study (Pence et al, 2007) also 
found that 29.5% of HIV infected people living in the Deep South had significant levels 
of anxiety. 
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In a South African sample of 85 patients recently diagnosed with HIV, a study by Martin 
(2007) revealed that 34 participants (40%) screened positive to post traumatic stress 
disorder related to HIV. Of those who met the criteria for PTSD, 82.4% were clinically 
distressed, 58.8% experienced high level of anxiety and 76.5% had depression. High rates 
of anxiety disorders were also reported in Nigeria where Adewuya et al. (2007) found 
that 12.5% of their sample screened positive to PTSD, 9.1% had social anxiety disorder, 
8% screened positive to generalized anxiety disorder, 6.8% panic disorder, 4.5% screened 
positive to specific phobia and 3.4% to obsessive compulsive disorders. 
According to McDaniel and Blalock (cited in Freeman et al., 2007), anxiety disorders 
among HIV infected patients has been associated with initial diagnosis, first opportunist 
infection, declining CD4 count, and the onset or progression of AIDS defining illness. 
PTSD in a study by Olley, Zeier, Seedat, and Stein, (2005) was found secondary to the 
diagnosis of HIV/AIDS and to a range of other traumas such as previous sexual violation 
and intimate partner violence. Similarly, Katz and Nevid (2005) found that PTSD in HIV 
infected patients was associated with past traumatic events, less satisfaction with social 
support, presence of physical symptoms related to HIV/AIDS, degree of negative life 
events and perceived stigma High death anxiety in HIV infected individual has been also 
found associated with the development of PTSD (Safren et al. 2003). On the other hand, 
HIV/AIDS is potentially a severe, life threatening illness and a trauma response to this 
potentially threatening experience does partially explain the increase of PTSD in this 
population (Whetten et al., 2008). 
2.3.4 Substance and alcohol use disorders among people living with HIV/AIDS 
Drugs and alcohol abuse have been found to be common among people living with HIV, 
as isolated disorders or in comorbidity with other mental disorders, (Freeman et al., 2007; 
Gallego, Gordillo, & Catalan, 2000; Pince et al., 2007). According to Freeman et al. 
(2007), substance abuse and dependence was high among their sample, with 12.4% 
reporting using alcohol and 2.9% having alcohol dependence, 1.9% use drag and 0.3% 
have developed dependence to drag. Pince et al. (2007) found a higher rate of drag use 
among HIV infected patients, where 70% of the sample reported drinking alcohol to 
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intoxication more frequently and 22% uses drugs. Similarly, Bing et al. (2001) found 
high rates of drug use, where 25.6% of the sample reported using drugs, with 12.5% who 
have developed drug dependence, and 12.3% reported heavily using alcohol. 
In studies comparing the rate of substance abuse among HIV infected women and non 
infected women, it was found that the proportion of women with a history of substance 
abuse or dependence was higher in the HIV-seropositive group (50.5%) than in the HIV-
seronegative women (30.6%), a difference they found to be statistically significant 
(Morrison et al., 2002). Similar difference was also found in a study by Sebit et al. (2003) 
who found that the prevalence rate of drug/alcohol use among Zimbabwean HIV positive 
subjects was high (24.3%) than among HIV negative subjects. 
Drug and alcohol use and misuse is known to increase the risk of HIV infection and 
transmission. Based on the findings from the HIV Costs and Service Utilization Study, 
individuals who had a history of drug and alcohol abuse were found more likely to 
engage in unprotected sex (Rand, 2007). Gallego et al. (2000) ; Khouzam, Donnelly and 
Ibrahim (1998) argue that not only do some drug substance abusers use direct intravenous 
injection, but also demonstrate risky behaviors such as sexual disinhibition, impaired 
judgment and impulsivity which increase their risk of infection and interfere with 
compliance with antiretroviral regimens. The results of HIV Costs and Service Utilization 
Study (Rand, 2007) also revealed that individuals with substance abuse or addiction, or 
those who were heavy drinkers were found to be non adherent to HAART than 
individuals without drug use. 
2.4 Risk factors for the development of depression among HIV 
infected patients 
A number of biological and psychosocial factors have been used to explain the link 
between the HIV/AIDS and psychiatric disorders (Chandra, Desai & Ranjan, 2005; 
Farber & McDaniel, 2002; Rao, Sagar, Kabra & Lodha, 2007). 
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2.4.1 Biological factors 
From a biological perspective, psychiatric disorders among HIV infected people may be 
caused by the direct involvement of HIV with the central nervous system, opportunistic 
infection, changes in metabolism and some treatments used (Cazullo, Bessone, 
Bertrando, Pedrazzoli & Cusini, 1998; Schwartz & Selwyn, 2001). According to Valente 
and Saunders, (in Valente, 2003) and Lochet et al., Fumaz et al. (in Rao et al., 2007) the 
HIV virus directly affects the central nervous system, and may damage neurons and 
impair cognition, thus causing depression. Faber and McDaniel (2002) state that 
precipitous changes in physical functioning, onset of opportunistic infections and 
neurocognitive decline may constitute the acute illness related stressors that may 
influence psychiatric disorders among HIV infected individuals. 
Furthermore, research has found that psychiatric disorders and particularly depression are 
more likely to occur at late stage of the disease progression, where HIV infected patients 
have a lot of symptoms associated with their HIV status and when their immune system 
is compromised (Bing et al., 2001, Kaharuza et al., 2006). Kaharuza et al. (2006) found 
association between HIV disease severity, as measured by CD4 counts and depression, 
where the findings of the study revealed that that the presence of depressive symptoms 
become more important when the CD4 counts become low. Similarly, using the World 
Health Organization staging criteria, Freeman et al. (2007) found that mental disorders 
were likely to be high in stage 3 and 4 of the disease, with a rate of 49.7% and 68% 
respectively. 
However, some studies have not found any relationship between the disease progression 
and depression. In their study, Morrison et al. (2002) did not find any significant 
correlation between different stages of illness progression and the proportion of 
depressive disorders. Their study found that depressive disorders were similar across 
different stages of HIV/AIDS illness according to CDC stage of illness. Griffin et al. (in 
Faber & McDaniel, 2002) and Rabkin, Ferrando, Lin, Sewell & McElhiney, (2000) 
suggested that it is the degree of physical limitation and physical symptoms severity, 
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rather than the disease progression itself that is more important in predicting 
psychological adjustment. 
A number of studies have shown that some antiretroviral agents precipitate psychiatric 
disorders among patients who had not previous psychiatric history (Halman, 2001; 
Foster, Olajide & Evarall, 2003). Medication used as antiretroviral therapy, especially 
efavirenz, has been found to be associated with a range of side effects on the central 
nervous system, including depression, nervousness, euphoria, hallucination and psychosis 
(WHO, 2008). Halman (2001) has indicated that some medications such as efavirenz, 
zidovudine, isoniazid, steroids, vinblastine and the protease inhibitors have been reported 
to cause depression and depressive symptoms. Morrison et al. (2002) found that although 
not statistically significant, the proportion of depressive disorders was higher among 
women who were receiving protease inhibitor therapy (29.0%) than women who were 
receiving antiretroviral therapy that did not include a protease inhibitor (14.5%). 
Foster et al. (2003) report a case of an HIV positive patient who presented with severe 
persecutory delusions, bizarre behavior and a labile and inappropriate mood which 
developed a month following the start of combination antiretroviral therapy of abacavir, 
nevirapine and combivir; her mental state resolved to premorbid stability once her 
medication was stopped. Similarly, De la Garza, Paoletti-Duarte, Garcia-Martin and 
Gutierrez-Cesares (2001) report a case of a woman who presented symptoms of 
confusion, disorientation, and feeling fearful at home, with paranoid delusions and 
insomnia. These symptoms appeared two days after efavirenz was added to her regime, 
and once efavirenz was discontinued, the mental state of the patient improved to 
premorbid stability. 
There are additional case study reports of manic symptoms (e.g. pressure of speech, 
grandiose delusions and agitation) occurring in patients being treated with zidovudine 
and acyclovir (Maxwell, Scheftner, Kessler, & Busch, 1998) and with zidovudine and 
aerosolized pentamidine (O'Dowd & Mc Kegney, 1988). Again, these symptoms 
resolved immediately the medication was stopped. These case studies concluded that the 
sudden appearance of psychotic symptoms and/or manic symptoms a month after starting 
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the antiretroviral therapy, together with the rapid resolution of symptoms after stopping 
treatment provides strong support for antiretroviral agent as possible cause of the 
psychotic and manic symptoms (De la Garza et al., 2001; Foster et al., 2003). 
2.4.2 Psychosocial factors 
HIV/AIDS imposes a significant psychological burden. The psychological reactions of 
adjustment to new illness, existence of premorbid psychiatric disorders and personality 
characteristics have been found to be associated with the emergence of psychiatric 
disorders among HIV infected patients (Faber & McDaniel, 2002). According to WHO 
(2008), in their attempts to adjust to the impact of being infected by that universally fatal 
illness and to other difficulties associated with it, HIV infected people often suffer mental 
illness. Issues such as shortened life expectancy, complicated therapeutic regimens, 
stigmatization, and loss of social support, increase that burden. Similarly, (Rabkin, 1995; 
Verdhana & Laxminarayana, 2007) state that the emotional shock associated with 
learning of HIV diagnosis presents a significant stressor that may increase the prevalence 
of mental disorders and this shock differs from person to person; some people may be 
overwhelmed with suicidal feelings whereas others will experience minor distress. 
Fear of present and anticipated negative life events such as an increased rate of early HIV 
progress, severely disrupted interpersonal relationships, life threatening illness, on-going 
exposure to loss and grief and feelings of helplessness, hopelessness, loneliness and utter 
despair have been found to trigger psychiatric symptoms and disorders in people living 
with HIV (Gallego et al., 2000; Rao et al., 2007; Valente & Saunders in Valente, 2003). 
Psychosocial factors such as lack of support, stigma, living alone, unemployment, have 
been also found associated to psychiatric disorders (Bing et al., 2002, Morrison et al., 
2002). According to Faber, Mirsalimi, Williams and McDaniel (2003), HIV infected 
individuals who are victims of stigma; discrimination and lack of social support are likely 
to suffer psychiatric disorders. Adewuya et al. (2007) reported possible correlation 
between marital status and lack of social support in psychiatric disorders, whereas 
Leserman et al. (2000) state that the availability of social support, a sense of belonging or 
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integration within a social network including primary partners, families, and/or friends 
and peers is associated with greater psychological adjustment in HIV/AIDS. On the other 
hand, some studies have found that people who are able to find positive meaning in their 
HIV status report high levels of psychological well being and are less likely to suffer 
depression (Faber et al., 2003). 
Other factors such as past psychiatric history have been found to be a risk factor to the 
development of psychiatric disorders among people living with HIV/AIDS. Studies have 
shown that people infected with HIV who had premorbid psychiatric history are likely to 
suffer psychiatric co-morbidity (Chandra et al., 2005; Verdhana et al., 2007). In their 
study, Chandra et al. (2005) found that all of the patients infected by HIV who attempted 
suicide had past history of psychiatric illness. Morrison et al. (2002) found that having a 
previous history of depressive disorders was a strong predictor of scoring high rate of 
depressive disorders among people living with HIV/AIDS than it was in non-infected 
people. Premorbid history of personality disorders has been found to be a strong predictor 
of psychiatric disorders, Jonhnson, William, & Goetz (as cited in Gallego et al., 2000). 
2.5 Impact of depression in the development and the treatment 
outcome of HIV/AIDS 
Depressive symptoms are associated with a variety of problems for people with 
HIV/AIDS. According to Adewayu et al. (2008) depression impacts negatively on quality 
of life of those infected by HIV/AIDS. Several studies (Cook et al., 2004; Leserman et 
al., 2000; Myer et al., 2008; WHO, 2008) have suggested that depressive disorders may 
speed the progression of HIV disease, and is associated with increased risk of AIDS-
related mortality. Leserman (2008) support that trauma, psychosocial stressors and 
depression can affect immunological progression of HIV/AIDS in terms of CD4 decline 
and increase in viral load. 
Depression has been found to be associated with lower overall health and poorer quality 
of life among people living with HIV/AIDS than with HIV-negative control groups 
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(Williams et al., 2005). In a study by Mayne et al. (cited in Berger-Greenstein et al., 
(2007) of women with HIV/ AIDS, it was found that there is a significant differences in 
mortality rates among women with and without depressive symptoms, where over a 
period of 7-year period of investigation, 8% of women who had few symptoms of 
depression had died, compared to 16% of women with intermittent depressive symptoms 
and 23% of women with chronic depressive symptoms. 
Meanwhile, depression and other mental illnesses were found to be associated with high 
risk behavior and substance abuse, which increase the risk for further transmission of 
HIV (Chander, Himelhoch & Moore, 2006). According to Rabkin (2008), symptoms of 
depression such as absence of pleasure, isolated life, impairment of social and 
professional abilities, have been found to negatively impact, not only on quality of life, 
relationships, but also associated with failure to respect a proper diet and exercise 
regimen. Starace et al. (2002) support that having a mental health illness may make 
following a daily routine more difficult and therefore complicate one's ability to adhere 
to a medicine regime. 
Depression is believed to influence adherence to antiretroviral treatment (Starace, cited in 
Starace et al., 2002). It is argued that symptoms of depression such as pessimistic 
thoughts, negative expectations, hopelessness, may dissuade patients living with HIV 
from adhering to antiretroviral or any other prescribed treatment. In the same view, the 
social withdrawal often found in people with depression limits the patient's abilities to 
request for help in adhering to medication regime (Starace et al., 2002). It is also believed 
that the fact of having dual diagnosis of depression and HIV expose people living with 
HIV to a risk of dual stigmatization, which can in turn affect their treatment adherence 
(Sirey et al,. 2001; Starace et al., 2002). 
Depression as factor of poor adherence was also reported in the WHO (2008) report on 
HIV and mental health, which states that strong evidence from high-income countries 
suggests that adherence to highly active antiretroviral therapy is lowered by depression, 
cognitive impairment, alcohol use and substance use disorders. In a study done by Singh 
et al. (cited in Angelino, 2002), poor compliance to antiretroviral treatment was related 
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mainly to the low interest in self-care manifested by patients who suffer depression. 
Berger-Greenstein et al. (2007); Olatunji et al. (2006) found that some of the symptoms 
of depression such as difficulty concentrating, fatigue and suicidal thoughts interfere with 
medication adherence among people with HIV. 
2.6 Issues related to the diagnosis of depression among HIV infected 
patients in a primary health care setting 
Despite the high rate of psychiatric disorders and depression in particular among HIV 
infected patients, research have found that these conditions are often undetected and 
consequently untreated (Israelski et al., 2007; WHO, 2008). In the light of this study, it is 
important to highlight some of these issues related to poor identification of depression in 
primary health care settings. 
In its practice guidelines, the American Psychiatric Association, [APA], 2000) reports 
that psychiatric disorders in HIV infected patients sometimes go "underdetected, 
misdiagnosed, undertreated, or treated improperly in primary care settings". Of 56% 
participants in a study by Israelski et al. (2007) who met criteria for three assessed 
psychiatric disorders, 43% reported no current treatment for any of these mental 
conditions. Similarly, Petrushkin et al. (2005) found that among a small sample of 46 
participants attending an urban clinic in Uganda, 38 screened positive for depressive and 
anxiety disorders, but none were receiving any treatment for their psychiatric disorders. 
In a study done by Asch et al. (2003) to estimate the extent to which depression was 
underdiagnosed among patients with HIV/AIDS, it was found that 37% of their sample 
(n:1140) have depression, yet only 46% of them were recognized as depressed by their 
health care providers. 
Some reasons for this underdetection of depression as pointed out by Rabkin (2008) is 
that in their routine work with people living with HrV, very few care providers ask them 
if they are depressed, and very few patients volunteer the information spontaneously. 
30 
Other researchers have identified different myths about depression that interfere with its 
diagnosis in people with HIV/AIDS. It is often believed that depression is an expected 
and common reaction to HIV/AIDS; that if patient with HIV/AIDS has got depression, 
he/she will obviously report it to his/her treating doctor and that suicide can be seen as 
understandable choice for people living with HIV/AIDS (Valente, 2003). However, it has 
been reported that not all people living with HIV/AIDS will have a mental health illness 
(Freeman et al., 2007). 
On the other hand, there are many resemblances in the clinical profiles of depression and 
of HIV, which sometimes complicate the diagnosis (Verdhana et al., 2007). The presence 
of somatic symptoms for depression such as weight loss, poor appetite, loss of energy and 
insomnia may be taken as part of the medical symptoms of HIV disease itself, therefore 
making difficult the diagnosis (Khouzam et al., 1998; Rabkin, 1995; Rabkin, 2008). 
According to Verdhana et al. (2007), the diagnosis may be further complicated by the 
presence of co-morbid neurological illness, substance abuse and use of multiple drugs, 
including antiretroviral drugs that are known to cause depressive symptoms as side 
effects. Valente (2003) recommends the use of screening instruments and reliable 
diagnostic methods to detect depression among people living with HIV/AIDS. 
Different tools have been used in the diagnosis of depression. The Beck Depression 
Inventory scale and the Center for Epidemiological Studies-Depression Scale are the 
most frequently used tests. The Beck Depression Inventory Scale contains 21 items 
describing depressive symptoms and their severity; it has been used by different 
researchers in detecting depression among people living with HIV/AIDS in public health 
settings and has high reliability and validity (Berger-Greenstein et al., 2006; Gibbie et al., 
2006; Judd et al., 2005; Kagee, 2008). The Center for Epidemiological Studies-
Depression Scale is a 20 items questionnaire, widely used to assess depressive symptoms 
over the previous seven days, and emphasizes on depressed mood, feeling of guilt and 
worthlessness, psychomotor retardation, loss of appetite and sleep disturbance (Kaharuza 
et al., 2006; Lyon & Younger, 2001). Researchers suggest that although the above scales 
may be useful in detecting depressive symptoms, patients who score above the normal 
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cutoff on these tools should be submitted to a more advanced assessment and a mental 
status evaluation for appropriate diagnosis and treatment (Valente, 2003). 
2.7 The role of the mental health nurse in the management of mental 
health problems associated with HI/AIDS. 
Mental health nurses, especially in low income countries are frequently the first mental 
health providers the patient encounter (Collins, 2006). This underscores the need to 
discuss their role in the management of mental health problems associated with 
HIV/AIDS. 
Although there are a limited number of studies about the role of the mental health nurse 
in the care of HIV/AIDS patients, the study that do exist strongly support the idea that 
these nurses contribute effectively to the care of people living with HIV either through 
collaboration with other team members in psychiatric consultation liaison, or individually 
as advanced psychiatric nurse practitioners (Allen et al., 2009; Weglarz & Boland, 2005). 
Their role in the management of mental health problems among HIV-infected persons has 
been found to comprise three main activities: participation in the assessment of mental 
health problems among HIV- infected patients, offering effective and supportive mental 
health care and participating in health-promoting activities (Allen et al., 2009; Valente, 
2003). 
In the assessment of mental health problems among patients affected by HIV/AIDS, 
Porche and Willis (2006) report that although generally nurses recognize the signs and 
symptoms of depression in HIV-infected patients, they infrequently use standardized 
scales and tools in their mental health assessment of these patients. Valente (2003) argues 
that the use of standardized screening scales helps nurses to recognize depressive 
symptoms which are often underestimated in their practice. It has been reported that 
advanced practice nurses can provide individual and group therapy using combined 
cognitive behavioral therapy and other modalities such as counseling, self-management 
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technique to effectively treat depression (Valente, 2003). Case management was also 
found in the studies to be one of the methods of care nurses can use to help HIV-infected 
patients (Porche & Willis, 2006; Husbands et al., 2007) did a study to assess the 
effectiveness of case management community care for people living with HIV/AIDS and 
found that the method was very beneficial to patients with depression. Patients who were 
very depressed and who received case management had 31% improvement in their 
mental health index, 45% improvement in social functioning, 16% improvement in 
physical function and 30% improvement in their mental health summary score. Patients 
have also reported being satisfied with the care provided by nurses. 
The role of the community-based mental health nurse in the care of people living with 
HIV/AIDS in one Australian city was evaluated by Allen et al. (2009). In this study, 
patients reported receiving effective empathic support, enhanced emotional support and 
reassurance from nurses. Patients felt they were being listened to and in this process, 
experienced relief from feelings of isolation and burden as the nurses assisted them to 
normalize and to contextualize their situation and experiences. This helped them to 
develop a more positive view of self and to consider other strategies to manage the 
difficulties associated with their disease into the future. 
Participating in health promoting activities has been identified as an important role of 
nurses in the management of mental health problems associated with HIV (Porche & 
Willis, 2006, Allen et al., 2009). According to Valente (2003), education helps the client 
to understand his/her disorder and to clarify which symptoms are related to depression 
and which to HIV or to treatment. This differentiation helps clients to understand their 
experience better and to engage with appropriate coping strategies. It also helps families, 
other care givers and care providers to increase their awareness and to provide effective 
support. The findings of the study by Allen et al. (2009) suggest that health promoting 
education was helpful, reassuring and alleviated participants' anxiety by increasing their 
awareness of depression and other mental health problems and by assisting them to 
change their perception of mental illness. This helped them to cope better with their 
problems. 
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These core roles can be accomplished within a stress-vulnerability framework which like 
the mental health nursing process, considers the patient and his/her experience within the 
context of personal and environmental strengths, issues, symptoms and protective and 
coping factors (Uys & Middleton, 2004). The main aim of the interventions within each 
of these roles is to assist the patient to live a meaningful and satisfactory life within the 
parameters of his/her illness by increasing the presence and action of protective factors, 
through psychiatric symptoms amelioration, increased adaptive functioning and improved 
quality of life (McDaniel et al. in Faber & McDaniel, 2002; Uys & Middleton (2004). 
The presence of professional psychiatric services such as regular and competent 
psychiatric symptoms assessment, education, psychopharmacological and 
psychotherapeutic interventions, all constitute protective factors in the patients coping 
and recovery (McDaniel et al. in Faber & McDaniel, 2002; Uys & Middleton, 2004; 
Valente, 2003). 
2.8 Conclusion 
This chapter highlighted the literature on mental disorders among people living with 
HIV/AIDS, with a focus on depression. It was noted that there is a higher rate of 
psychiatric disorders among people living with HIV/AIDS than in non- infected people. 
The common psychiatric disorders were mood disorders, anxiety disorders, and suicide 
and drug/alcohol abuse. Depression was found to be the most prevalent disorder with a 
prevalence ranging from 5% up to 48%, depending on the population studied (Hartzell, 
Janke, & Weintrob, 2008). Factors associated with the risk of depression among people 
living with HIV/AIDS were reviewed, and can be summarized into two categories; 
biological factors and psychosocial factors. Finally, some of the issues related to the 
diagnosis of depression in HIV infected patients leading to poor treatment outcomes were 
reviewed and the role of the mental health nurse in working with this population was 
emphasised. 





This chapter describes the research approach, setting and design. This includes a 
discussion of the sampling procedure, tools that were used to collect data, how data was 
managed and analyzed, the ethical issues that arose during the course of the study and the 
precautions that were taken to manage these. 
3.2 Research paradigm and approach 
This research study is based on a positivist and quantitative understanding of how the 
social (including experience) and physical world can be known and studied (Terre 
Blanche, Durrheim & Painter, 2006). This paradigm argues that it is possible to 
understand and to describe the reality of specific phenomena through direct observation 
and measurement of its discrete aspects (O'Leary, 2004). Data derived from observation 
and measurement is therefore numerically represented, is shown to be true beyond chance 
and has applicability beyond the sample to a wider population (Burns & Grove, 2005; 
O'Leary, 2004; Terre Blanche et al., 2006). 
The study aims to explore the prevalence rate of depression among people living with 
HIV/AIDS and the extent of the association between depression and the specific 
HIV/AIDS medical factors and socio-demographic factors commonly associated with 
depression in this population. A quantitative approach is therefore suitable for this study 
because it represents these observations and the relationship among them in explicit, 
numerical terms (Babbie, 2007). 
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3.3 Research design 
A descriptive cross-sectional design informs this study. The purpose of a descriptive 
cross-sectional study in health research is to observe and to describe the status of a 
phenomenon and the relationships among specific aspects of the phenomenon during one 
period of data collection (Morroni & Myer cited in Joubert & Ehrlich, 2007; Polit and 
Beck, 2008). The status of a phenomenon or condition in health research is commonly 
measured in terms of prevalence (the extent to which a phenomenon is present in a 
population at risk) and/or incidence (the frequency of new cases) at a single point in time 
(Polit and Beck, 2008). 
A descriptive cross-sectional design was used to study the prevalence of depression and 
the relationships among depression, sociodemographic and HIV/AIDS related medical 
indicators in adults living with HIV/Aids and attending the Kimironko Health Centre in 
Kigali, Rwanda. 
3.4 Research setting 
This research was undertaken at the Kimironko Health Centre in Rwanda. This centre is 
situated in the heart of Kigali city, and is thus regarded as an urban public health service. 
The centre was established in 1998 to provide routine health care for this urban 
population. It began offering comprehensive HIV care and antiretroviral (ARV) treatment 
in 2003 and was one of the first health services to offer ARV treatments (Griensven et al., 
2008). 
Currently, approximately 3700 HIV positive people are enrolled with the centre for care 
and treatment for HIV related illness (annual report of Kimironko Health Centre, 2008). 
The service offers ARVs prophylaxis, treatment of opportunistic infections, blood 
measurement for CD4 cell counts and viral load, and psychosocial care. 
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3.5 Research population 
Polit and Beck (2008) define a population as all the individuals or objects with common, 
defining characteristics. Establishing prevalence requires that this population be at risk 
for the condition being studied. In the case of this study, the population at risk for 
depression is comprised of all HIV infected patients attending the Kimironko Health 
Centre for HIV/AIDS treatment. According to the annual report of Kimironko Health 
Centre (2008), the centre lists a population figure of 3700 people living with HIV and 
who are followed for care and treatment. 
3.5.1 Inclusion criteria 
The sample included all participants who have tested HIV positive; who are currently 
receiving care and treatment for their HIV/AIDS status at Kimironko Health Centre; and 
who are over the age of 18 years and therefore legally able to consent to participate in the 
study. 
3.5.2 Exclusion criteria 
Participants who are under the age of 18 years of age were excluded from the study 
population. Participants were not excluded on the basis of literacy. Although the tool 
used in this study is self-administered, participants were offered the opportunity to have 
the researcher work through the questionnaire with them. 
3.6 Sampling procedures 
3.6.1 Sampling procedure 
A sample is defined as a subset of the population that is selected for a particular study 
while sampling is the process through which a group of people and/or events are selected 
for study (Burns & Grove, 2005). Probability, simple random sampling technique was 
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used to select participants for this study. According to Polit and Beck (2008), probability 
sampling involves the random selection of elements from the population, whereby each 
element has an equal, independent chance of being selected. The simple random sampling 
involves the use of a sampling frame. 
In this study, a sampling frame was defined based on the list of all patients living with 
HIV/ADDS attending the Kimironko Health Centre who were scheduled for appointment 
during the 12 days data collection, between the 20* July and the 3rd August. In total, 349 
patients were scheduled for appointment during that period. Permission to use the 
patients' files to obtain the file codes for all the scheduled patients was sought from and 
granted by the clinic's manager (see appendix 3.3 for this permission). A list of all 
patients identified by files codes was made and numbered and a table of random numbers 
was used to select the desired sample size from the sample frame. 
3.6.2 Calculating the sample size 
The sample size was calculated based on the following formula provided by Sayed (cited 
in Joubert & Ehrlich 2007). 
n=pfl-p)z2 
d2 
Where p is the anticipated population proportion, d is the precision required on either side 
of the proportion, and z refers to the cutoff value of the normal distribution and is based 
on a 95% confidence limit (=1.96). 
No prevalence data for depression among people living with HIV/AIDS is available for 
Rwanda. Therefore, 50% was used to anticipate the proportion of the population of 
people living with HIV and who experience depression. This was supported by 
Katzenellenbogen, Joubert and Abdool Karim (1997) who state that when the proportion 
or average of the true population presenting with the outcome variable is not known, an 
estimate of proportion (p) of 0.5 shall be used. A total of 10 percentage points of error 
was tolerated on each side of the estimated proportion, expressed as d = 0.1. 
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Therefore: n= 0.5(1-0.5U1.96? 
(0.1)2 
The sample size in this study was 96 people living with HIV/AIDS attending Kimironko 
Health Centre during the data collection phase. 
3.6.3 Procedure for selecting the participants 
Participants were randomly selected from a list of all patients scheduled for appointment 
during the period Monday 20th July and Monday 3rd August. In total, 349 patients were 
scheduled during that period. These were identified through their codes, and a random 
sampling table was used to select 96 participants for the sample. A list of codes for 
selected patients and their dates of appointments was given to the consulting nurses to 
recruit participants. The selected patients were directed by the clinic staff to the office 
assigned to the researcher as they arrived at the clinic. The researcher introduced herself 
to each patient, explained the purpose of the study, outlined the inclusion criteria and 
finally, invited those who met the inclusion criteria to participate. Those who were 
approached and agreed to participate were included in the sample. 
The anticipated sample size of 96 was not achieved during this period. Fifteen of the 
randomly selected patients did not arrive at the clinic and either sent their relatives to 
collect their medication or simply did not arrive for their scheduled clinic appointment. 
Five additional participants were selected and approached to participate but were unable 
to participate because of personal time constraints. In order to achieve the desired sample 
size (n=96), it was therefore necessary to add a further two days for data collection (4th 
and 5th August). The same procedure was used to collect data during this time. All 
patients scheduled during the two days were added to the list and then fifteen were 
randomly selected and approached. A total sample of 96 people living with HIV was 
therefore reached with these additional two days. 
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3.7 Data collection instruments 
Two data collection instruments were used to collect data for this study and are contained 
in appendix 1. Each of these instruments and their forms of measurement are briefly 
described. 
3.7.1 Socio-demographic and medical information 
A structured questionnaire was developed and used to collect socio-demographic 
characteristics and medical information related to HIV/AIDS. Demographic data includes 
variables such as age, gender, marital status, socioeconomic status, employment, 
perceived level of social support and the presence of a pre-morbid psychiatric history. 
These are the variables most commonly used in studies of HIV status and psychiatric co-
morbidity (Adewuya et al., 2007; Israelski et al., 2007; Komiti et al., 2003; Morrison et 
al. 2002). Medical data related to HIV/AIDS includes the CD4 cell count, the length of 
time participants have know their HIV status and the presence of HIV related medical 
symptoms. The decision to use these variables is based on previous studies (Berger-
Greenstein et al., 2006; Gibbie et al., 2006; Judd et al., 2005; Komiti et al., 2003). See 
appendix 5 for a summary of these studies. 
Demographic data were obtained directly from each participant, either through self-
reporting or through a brief interview process in the case of those participants who were 
unable to read or to write Kinyarwanda or who expressed a preference for the researcher 
to work through the questionnaires with them. 
The medical information was obtained from the participants and the CD4 count 
information was verified in the files for those participants who were unable to remember 
their CD4 counts measures. Written permission to access the patients' files was requested 
from and granted by the center manager (see appendix 3.3). 
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3.7.2 Depression information 
The presence of depression among people living with HIV/AIDS was assessed using 
Beck Depression Inventory Scale. According to Berger-Greenstein et al. (2006) the BDI 
is a widely used and accepted brief screening instrument for depression that can easily be 
adapted to the clinical setting. One of the many advantages of the scale is that it takes a 
short time to complete and has been used in other previous, similar studies (Berger-
Greenstein et al., 2006; Gibbie et al., 2006; Judd et al., 2005; Kagee, 2008). 
The scale takes approximately 10 minutes to complete. Twenty-one items describing 
depressive symptoms and their severity are ranked along an ordinal continuum from 
absent (0) or mild to severe. Respondents are required to rate each item from 0 - 3 
according to how they have felt during the past week (Gibbie et al., 2006). According to 
Beck, Steel and Garbin, (in Berger-Greenstein et al., 2006) the summed scores range 
from 0 to 63. A score of 14 or more is widely used as a cut-off score indicating 
depression when using the 21-item BDI (Gibbie et al., 2006). In this study, the cut-off 
used in Kagee's (2006) study was considered to score depressive symptoms among 
people living with HIV/AIDS where a score of 0-9 was considered as normal range; 10-
18, mild to moderate depression; 19-29, moderate to severe depression and 30-63, severe 
depression. 
The Beck Depression Inventory Scale was translated in Kinyarwanda to produce local 
terms equivalent to the scale's items (see appendix 1.2). The translated version was 
submitted to and reviewed by two local teams: the department of mental health of the 
Kigali Health Institute and the department of Linguistics of the National University of 
Rwanda. The linguistic team helped to construct the items of BDI in Kinyarwanda terms, 
and the team from the mental health department validated the mental 
health/psychological sense of the terms, such as getting the appropriate meaning of 
"depression" in Kinyarwanda. 
The reviewed scale was administered to five people living with HIV/AIDS in order to 
ensure that the terms and concepts and instructions were understandable. The respondents 
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were assisted by the researcher to complete the Beck Depression Inventory Scale. There 
was ambiguity in the instruction given about circling all the responses that described the 
way they have been feeling in the last week, including the day of interview. This 
instruction was changed to read 'circle the one statement which best describes the way 
they have been feeling in the last week'. 
3.8 Validity and reliability of the tool 
Validity refers to the degree to which an instrument measures what it is supposed to 
measure. There are various approaches to validating an instrument, such as content 
validity, criterion related validity and construct validity (Polit & Hungler, 1999). In this 
study, content validity was applied to validate the data collection tool. Table 3.1 below 
highlights the content validity and shows which items of the measurement correspond 
with which study objectives. 
Table 3.1 Summary of content validity: Objectives and Measurements 
Research objectives 
Explore the prevalence rate of depression among 
HIV infected patients attending the Kimironko 
Health Center 
To describe the clinical profile of depression 
among HIV infected patients 
To estimate the extent to which socio-
demographic factors are associated with 
depression in people living with HIV. 
To estimate the extent to which HIV medical 
related indicators are associated with depression. 
Item for measurement 
Beck Depression Inventory Scale (BDI) 
Item 1-21 
Beck Depression Inventory Scale (BDI) 
Item 1-21 
Self-administered questionnaire 
Part 1: Section 1-9, together with the BDI 
will help to determine the extent of 
association between these variables 
Self-administered questionnaire 
Part 2: Section 10-14, together with the BDI 
will help to determine the extent of 
association between these variables 
Concepts within the conceptual framework 
Increased biological vulnerability (HIV related 
medical information). 
Decreased social and personal protective factors 
(Socio-demographic factors). 
Presence or absence of depression. 
Self-administered questionnaire 
Part 2: Section 10-14 
Self-administered questionnaire 
Part 1: section 1-9 
Beck Depression Inventory Scale (BDI) 
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Beck Depression Inventory Scale has been used in different depression studies and has 
been shown to have high validity and reliability in measuring depressive symptoms. In a 
study by Berger-Greenstein et al. (2006) Beck Depression Inventory was used to assess 
major depression in patients with HIV/AIDS. The scale was also used in a Rwandan 
context by Hangengimana et al. (2003) to assess depressive symptoms in a sample of 
genocide survivors and these authors found it to be reliable although the reliability 
figures were not presented. The instrument was received from the first author as this 
project was being written up, but without the reliability figures. The content of the 
Hangengimana et al. (2003) instrument and the one adapted for this study were compared 
and found to be very similar, except for few items where the sentences construction 
differed. This difference did not seem to affect the interpretation of the instructions for 
either questionnaire. 
The Beck Depression Inventory scale has also been used in different South African 
contexts. Kagee (2008) used it to determine the prevalence rate of depression among 
patients with chronic illness and the scale's internal reliability as measured by 
Cronbach's alpha was 0.85. In the current study Cronbach's alpha was 0.83. 
3.9 Data collection procedure 
The researcher collected the data with the help of a research assistant. The research 
assistant was a psychiatric nurse with an advanced diploma in psychiatric nursing. She 
was oriented to the use of the Beck Depression Inventory and the ethical principles of 
confidentiality and data management prior to her involvement with data collection. 
Data collection commenced after all required ethical approvals were obtained including 
permission to conduct the research at Kimironko Health Care Center and permission to 
view the patients' files (please see Appendices 3.1, 3.2 and 3.3 for these letters of ethical 
approval).The researcher then approached the nurses in the HIV service to discuss how 
participants would be identified and the referral process that would be followed in the 
case of adverse events occurring during the data collection process. It was agreed that the 
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researcher will manage the events and if a referral was necessary, the normal referral 
procedure of the service would be used. No adverse events occurred during data 
collection although some participants became tearful and some angry about their illness 
and/or social support. In these instances, the researcher allowed them to talk through their 
feelings before moving on to complete the questionnaire. 
The researcher contacted the mental health service at the district hospital and set up 
appointments and provided referral letters for those who scored severe depression. One 
participant was already receiving treatment and participating in follow up care and was 
therefore not referred. Another participant with a previous history of attempted suicide 
reported thoughts of self-harm and was referred to the mental health outpatient service 
for immediate follow-up. The researcher made the appointment for the patient and wrote 
a letter of referral. Those who reported moderate depressive symptoms were also advised 
to consult the district hospital while others who reported mild depressive symptoms were 
scheduled to see the social worker of the health center. 
The researcher and her assistant were at the clinic on a daily basis from 8:00 until all the 
patients scheduled for the day were seen. Each morning, a list of patients scheduled for 
that day was given to nurses, and the selected participants were referred to the allocated 
offices where they met with either the researcher or the research assistant. Once the 
participant agreed to participate she/he was given a letter of information and signed the 
informed consent. Although the instrument is designed as a self-completion 
questionnaire, all the participants expressed a preference for the researcher to work 
through the questionnaire with them. It took approximately 20-30 minutes to complete 
each questionnaire. Participants who experienced emotions such as crying were given 
time to debrief and were asked if they were still willing to continue. None of the 
participants asked to be withdrawn from the study. 
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3.10 Data analysis 
Data was analysed using the Statistical Package for the Social Sciences (SPSS for 
window) version 15. Appendix 5 summarises the variables and types of measurement and 
statistical analyses that were performed. To estimate the prevalence of depression, 
descriptive statistics, using frequencies, mean and standards deviation were performed. 
The categorical variables in this study (gender, marital status, level of social support, 
employment status, socio-economic status, symptoms of illness and history of psychiatric 
disorder) were correlated with the depression score using Chi-square test. Polit and 
Hungler (1999) state that the chi-square (%2) test is a commonly used method for 
comparing frequencies or proportions among categorical variables and is used to test the 
significance of the effect of one variable (e.g. HIV/AIDS) upon an outcome (depression). 
To analyze the extent to which numerical variables (age, support score, CD4 cell counts 
and duration of known HIV status) are associated with depression, the t-test for 
independent sample test was used. According to Jackson (2009), the t test for a single 
sample is a parametric statistical test of the null hypothesis for a single sample. It is used 
to determine the number of standard deviation units a score is from the mean of a 
distribution. It is used when the researcher wants to compare the mean scores of two 
different groups of people or conditions for the purposes of assessing if there is any 
significant difference in the mean scores. (Terre Blanche et al., 2006). 
3.11 Data management 
All the data collected will be used for the purpose of this study only. Hard copy 
completed questionnaires and computer data were kept confidential, under lock and key. 
Data were stored during the study on a computer which has a code of access known only 
to the researcher. Paper will be shredded after a period of 5 years and data stored on the 
computer will be erased from both the programme files and the recycle bin. 
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3.12 Ethical considerations 
This study deals with two very sensitive issues: depression and HIV/AIDS. The 
researcher strived to protect and to respect the privacy, anonymity and wellbeing of 
persons with these conditions. 
Three types of data were collected for the purpose of this study, neither of which contains 
identifying information, thus ensuring the anonymity of the participants. A consent to 
participate form and an outline of the purpose of the study were discussed with each 
client who agreed to participate (see appendix 4). This form indicated that participation is 
voluntary, and that clients have the right to withdraw from completing the questionnaire 
at any time they wish. Participants were assured that if they wished to decline to 
participate, their care or dignity would not be compromised in any way since there is no 
relationship between participation and health or treatment outcome. No participant 
declined to participate in the study. Participants were also informed that there is no 
expectation of additional treatment or any benefits for them associated with participating 
in the study but that those who scored high on the depression scale were referred to a 
specific person at the clinic for assistance. 
The study commenced once the research proposal has been approved by the research 
ethics committee of the University of KwaZulu-Natal, the research committee of the 
National AIDS Control Commission (CNLS) in Rwanda, and the Kimironko Health 
Centre management (these documents can be found in Appendices 3.1, 3.2 and 3.3). 
3.13 Conclusion 
This chapter outlined the research methodology followed in this study. It also highlighted 
the procedure that was used to collect the data as well as the measures taken to ensure 
that ethical considerations involved in this study were protected. The following chapter 





This chapter presents the findings of the study. The main aim of the study was to explore 
the prevalence of depression among people living with HIV/AIDS and to analyze the 
association between selected socio-demographic data and medical information with 
depression. Data collection was done using two types of data collection tools: a socio-
demographic questionnaire and Beck Depression Inventory Scale (BDI). A description of 
the socio-demographic characteristics of the sample is presented, followed by data on 
depression score of the participants obtained from BDI. 
The primary outcome measure for this study was depression as measured by BDI. 
Depression scores were summed using the cutoff of 0-9 for a normal range, 10-18 for a 
mild to moderate depression, 19-29 for a moderate to severe depression and 30-63 for a 
severe depression. All the scores above 10 (beginning of the mild-moderate depression 
range) were then grouped into "depressed" and the scores below 10 were grouped into 
"not depressed". 
Analysis was done using the Statistical Package for the Social Sciences (SPPS) for 
Windows, version 15. Cross tabulations and Pearson's Chi-square analysis were used to 
determine the extent of relationship between socio-demographic factors and medical 
factors with depression. A p value of < 0.05 was considered as statistically significant. 
Logistic regression was later performed to determine each of these factors and how they 
are associated with a BDI score greater than 10. Only factors that have been found to be 
significantly associated with depression score in cross tabulation and in chi square 
analysis were entered into the logistic model, using a backward stepwise approach. With 
a confidence interval of 95%, factors that had ap value less than 0.05 were retained in the 
final model. 
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4.2 Description of the socio-demographic characteristics of the 
sample 
Ninety-six people living with HIV/AIDS attending a selected primary health care center 
in Kigali constituted the sample size for this study. This sample was randomly selected 
from a total sampling frame of 349 patients who were scheduled during the period of data 
collection. The sample size was 27.5% of the total sampling frame for this study. 
4.2.1 Age of respondents 
The minimum age of the respondents in the sample was 18 years and the maximum was 
62 years with a mean of 39.15 years, a median of 38 years and a standard deviation (SD= 
9.121). As it appears in the following histogram, the ages of respondents were normally 
distributed, since most ages were close to the mean age, and only very few were 
distributed to one and other side of the mean. 
Mean =39.15u 
Std. Dev. =9.1211 
N = 9 6 
30 40 50 
Age of respondents 
r 
70 
Figure 4.1 age of respondents 
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4.2.2 Gender of respondents 
The largest proportion of the total sample (n=96) were female (67 at 69.8%) and 29 
(30.2%)) were male. 
4.2.3 Employment and amount of money for daily living 
Thirty-seven (38.5%) of the respondents were employed, whereas 59 (61.5%) were not 
employed. About 54 (56.3%>) of the participants in the sample were able to afford more 
than 250 Rwandan Franc for their daily living, and 42 (43.8%) earned less than 250 
Rwandan Franc for their daily living. This suggests that under half of the sample in this 
study lives under poverty line. According to the Second Integrated Household Living 
Conditions Survey of 2007, a person in Rwanda who consumes less than 250 Rwandan 
Franc per day is classified as poor (National Institute for Statistic [NIS], 2007). 
4.2.4 Relationship status and living arrangement 
The majority of the sample, 40 out of 96 (41.7%) were married, 27 (28.1%) were 
widowed, 14 (14.6%) were divorced, 10 (10.4%) were single and 5 (5.2%>) were 
cohabitating. More than half the sample, 63 (65.6%>) were living with their family, that is, 
living with husband or wife, children and/or siblings. Thirty-two (33.3%) of the 
respondents lived alone whereas only 1 (1.0%) was living with friends. 
4.2.5 Satisfaction with received support 
Five supports domains were assessed: support from family, from neighbors and friends, 
support from other social networks and from other people living with HIV/AIDS, using a 
scale from 0 meaning extremely dissatisfied to 5 extremely satisfied with support. All 
these supports scores were added together to make an overall support score out of a 
maximum of 20. 
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The minimum support score was 0 and the maximum was 19, with a mean of 11.80 and a 
standard deviation (SD=3.897). The majority of respondents were overall satisfied with 
the received support, (Figure 4.2), which is slightly skewed negatively. This means that 
the majority of the sample scored high above the mean in the level of satisfaction with 
support. 
Mean =11.80 
Std. Dev. =3.897C 
N =95 
Support score 
Figure 4.2: Support score 
4.2.6 Previous psychiatric history 
None of the participants had a past history of psychiatric disorders before learning of 
their HIV status and 82 (85.4%) of the total sample did not have a history of psychiatric 
disorder in their family. Only 14 (14.6%) had a past psychiatric history in the family, 
though none could identify the name of the psychiatric disorder of their family member. 
These socio-demographic characteristics are shown in table 4.1. 
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Amount of money for daily 
living 
Living arrangement 
Past personal psychiatric 
history 
Past psychiatric history in 
the family 
Attributes Frequency Percentage 
Male 29 30.2% 
Female 67 69.8% 
18-30 16 16.7% 
31-41 39 40.6% 
42-52 34 35.4% 
53-63 7 7.3% 
Single 10 10.4% 
Married 40 41.7% 
Divorced 14 14.6% 
Cohabitating 5 5.2% 
Widowed 27 28.1% 
Employed 37 38.5% 
Not employed 59 61.5% 
Less than 250 Frw 42 43.8% 
More than 250 Frw 54 56.3% 
Live with family 63 65.6% 
Live with friends 1 1.0% 
Live alone 32 33.3% 
Yes 0 0 
No 96 100% 
Yes 14 14.6% 
No 82 85.4% 
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4.3 Description of the medical information of the sample 
4.3.1 Duration of known HIV status 
The minimum time in years that the respondents in this study (n=93) have known their 
HIV status was 1 year and the maximum was 15 years, with a mean of 5.20 and a 
standard deviation (SD=2.869). The figure shows that the distributions of duration of 
know HIV status is slightly skewed positively bellow the mean. This means that the 
majority of the samples have known their HIV status in a period less than the mean (5.2). 
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Figure 4.3: Duration of known HIV status 
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4.3.2 Number of visits to and admissions in the hospital 
Seventy-one (74.0%) of the participants had not visited the hospital in the last month for 
any reason related to their HIV status other than medication supply and laboratory blood 
values checkup. 14 (14.6 %) visited the hospital once and 10 (10.4%) visited the hospital 
more than once. Of those who visited the hospital, 4 (4.2%) were admitted into hospital 
in the last month while 91 (94.8) were never admitted into hospital. 
4.3.3 CD4 cell counts 
The CD4 cell counts from 91 respondents were considered. Five respondents did not 
provide their CD4 cell counts and did not provide the code number for their files to allow 
the researcher to access them. Therefore, these have been considered missing values. 
The minimum CD4 cell count of respondents in the sample (n=91) was 50 and maximum 
CD4 cell counts was 1034, with a mean of 380.97, and a standard deviation (SD= 
193.396). The distribution of CD4 counts measure is slightly skewed positively below the 
mean, which means that the majority of respondents in the sample scored CD4 counts 
less than the mean CD4 counts score (380.97). This is illustrated in figure 4.4. 
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Mean =380.970 
Std. Dev. =193.396Z 
N =91 
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Figure 4.4 CD4 Counts 
4.3.4 HIV related symptoms 
About 54 (56.3%) of the sample did not present any symptoms related to their HIV status 
in the month preceding data collection, 17(17.7%) presented unexplained weight loss, 13 
(13.5%) presented recurrent respiratory infection, 3 (3.1%) presented recurrent oral 
ulceration, 2 (2.1%) presented chronic diarrhea and 7 (7.3%) presented other symptoms. 
Other symptoms comprised of persistent headaches, forgetfulness, urinary infection, 
tuberculosis, neurological pain and abdominal pain. The medical characteristics of the 
sample are shown in table 4.2. 
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Table 4.2 HIV medical related information of the sample 
Medical related 
variables 
Time known HIV 
status 
Visit to the hospital in 
last month 
Admission in hospital 
















Unexplained weight loss 
Recurrent respiratory 











































4.4 Prevalence of depression among people living with HIV/AIDS and 
attending the selected primary health care center in Kigali 
The prevalence of depression was assessed using Beck Depression Inventory Scale. The 
scale constitutes a total score of 63. A score from 0 to 9 was considered normal (not 
depressed) and all the scores above 9 were considered depression. 
As shown in table 4.3, of the total sample (n=96), 56 (58.3%) of respondents scored less 
than 9 and therefore they were considered not depressed, whereas 40 (41.7%) had a score 
above 9 and they were considered depressed. With a 95% Confidence Interval, the total 
prevalence of depressed participants is in the range between 31.83% - 52.18%. 
This suggests that the prevalence of depression among people living with HIV/AIDS and 
attending the selected primary health care center, based on Beck Depression Inventory 
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Scale, was 41.7%, with 95 % confidence that the prevalence ranges between 31.83% and 
52.18%. 














: 41.67 [31.83,52.18] 
This finding corresponds to the first objective of this study which was to explore the 
prevalence of depression among people living with HIV/AIDS attending a primary health 
care center in Kigali. 
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4.5 Clinical profile of depression among people living with HIV/AIDS 
attending the selected primary health care center in Kigali 
Respondents who scored from 0 to 9 score in Beck Depression scale were considered not 
depressed, those with a score between 10-18 were considered as having a mild to 
moderate depression, those with a score between 19-29 were considered having moderate 
to severe depression and those with a score above 30 to 63 were considered as having 
severe depression. 
The findings of this study showed that 56 (58.3) of the respondents (n= 96) scored the 
normal range score, 26 (27.1%) scored mild to moderate depression, 12 (12.5%) scored 
moderate to severe depression and 2 (2.1%) scored severe depression. This is shown in 
the following graph 4.1. 
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60.0%-
Normal range Mild to moderate Moderate to Severe 
Severe Depression 
Graph 4.1 Profile of depression 
To estimate the profile of depression among people living with HIV/AIDS, respondents 
who scored within the normal range, in other words those who were not depressed (56 
respondents) were not considered. Therefore those who scored depressed, who had a 
score greater than 9 on Beck Depression Inventory, was considered (n=40). 
The following graph 4.2 shows the proportion of depression severity in respondents who 
scored positive to depression. It shows that out of all the depressed respondents (n=40), 
26 respondents (65.0%) scored within the range of 10-18 and are therefore mild to 
moderately depressed, 12 respondents (30.0%) scored within the range of 19-29 
(moderately to severely depressed) and 2 respondents (5.0% ) scored within the range of 
30-63 and are therefore severely depressed. 
58 
This means that 65.0% of all the depressed respondents had mild to moderate depression, 
30.0% had moderate to severe depression and 5.0% had severe depression. 
Mild to moderate Moderate to severe Severe Depression 
Depression Depression 
Graph 4.2: Depression profile 
Graph 4.2 Clinic profile of depression 
Particular clinical symptoms for depression commonly presented by respondents in this 
study were analyzed. 
The most common depressive symptoms that were presented by depressed respondents 
(n=40) were pessimism and fatigability (37), followed by sad mood (36); lack of 
satisfaction (35), somatic preoccupation (31), loss of libido (30), crying spells (29), work 
inhibition (28), irritability, social withdrawal and loss of appetite (23). The difference in 
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all these symptoms was statistically significant when compared the depressed to non 
depressed respondents (p values ranging from < 0.001 to 0.016). 
Although a significant number of depressed respondents (32 out of 40) did not have self-
punitive wishes, 6 of them have had thoughts of self-harm before, and 2 expressed that 
they would like to kill themselves. Again this difference was statistically significant 
(p=0.026) when comparing the depressed respondents to non-depressed respondents. 
More than half of depressed respondents did not have guilty feelings (21 out of 40) and 
did not feel a sense of punishment (24 out of 40). The p value for these two symptoms 
were not statistically significant (p=0.223 and 0.180) respectively. 22 out of 40 depressed 
respondents presented preoccupations with their body image, but this difference was not 
statistically significant compared to non depressed respondents (p=0.08). This is 
illustrated in table 4.4 below. 
This responds to objective two of this study which was to describe the clinical profile of 
depression among people living with HIV/AIDS attending a primary health care center in 
Kigali. 
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Table 4.4 Frequency of clinical symptoms 
Mood 
Pessimism 
Sense of failure 
Lack of satisfaction 
Guilty feelings 
Sense of punishment 
Self hate 
Self accusation 
Self punitive wishes 
Crying spells 
I do not feel sad 
I feel sad 
I am sad all the times 
I am so sad and unhappy 
I am not discouraged 
I am discouraged about the future 
I have nothing to look forward to 
the future is hopeless 
I do not feel like a failure 
I have failed more than the average 
All I see is a lot of failure 
I get satisfaction as I used to 
I don't enjoy things as I used to 
I don't get satisfaction anymore 
I am dissatisfied with everything 
I don't feel guilty 
I feel guilty a good part of time 
I feel guilty most of the time 
I feel guilty all of the time 
I don't feel punished 
I feel I may be punished 
I expect to be punished 
I feel I am being punished 
I don't feel disappointed 
I am disappointed 
I am disgusted 
I hate myself 
I don't feel worse than other 
I am critical of myself 
I blame myself 
I don't have thoughts of killing myself 
I have thoughts of killing myself but I would not 
I would like to kill myself 
I would kill myself if I had a chance 
I don't cry than usual 
I cry now more than I used to 
I cry all the time now 
Depression Total % Value P Valui 
Not depressed Depressed 
25(44.6%) 4(10.0%) 29(30.2%) 
31(55.4%) 24(60.0%) 55(57.3%) 26.158 < 0.001 
0(0.%) 11(27.5%) 11(11.5%) 
0(0.%) 1(2.5%) 1(1.0%) 
29(51.8% 3(7.5%) 32(33.3%) 
26(46.4%) 29(72.59%) 55(57.3%) 
1(1.8%) 5(12.5%) 6(6.3%) 24.983 < 0.001 
0(0.0%) 3(7.5%) 3(3.1%) 
45(80.4%) 22(55.0%) 67(69.8%) 
11(19.6%) 14(35.0%) 25(26.0%) 9.863 0.007 
0(0.0%) 4(10.0%) 4(4.2%) 
26(46.4%) 5(12.5%) 31(32.3%) 
28(50.0%) 20(50.0%) 48(50.0%) 23.547 < 0.001 
2(3.6%) 14(35.0%) 16(16.7%) 
0(0.0%) 1(2.5%) 1(1.0%) 
38(67.9%) 21(52.5%) 59(61.5%) 
18(32.1%) 17(42.5%) 35(36.5%) 4.382 0.223 
1(2.5%) 1(1.0%) 
0. (0.0%) 
0(0.0%) 1(2.5%) 1(1.0%) 
43(76.8%) 24(60.0% 67(69.8%) 
13(23.2%) 14(35.0%) 27(28.1%) 4.894 0.180 
0(0.0%) 1(2.5%) 1(1.0%) 
0(0.0%) 1(2.5%) 1.(1.0%) 
53(94.6%) 28(70%) 81(84.4%) 
3(5.4%) 10(25.0%) 13(13.5%) 11.128 0.011 
0(0.0%) 1(2.5%) 1(1.0%) 
0(0.0%) 1(2.5%) 1(1.0%) 
47(83.9%) 19(47.5%) 66(68.8%) 
7(12.5%) 15(37.5%) 22(22.9%) 14.525 0.001 
2(3.6%) 6(15.0%) 8(8.3%) 
55(98.2) 32(80.0) 87(90.6) 
1(1.8) 6(15.0) 7(7.3) 
0(0.0) 1(2.5) 1(1.0) 9.242 0.026 
0(0.0) 1(2.5) 1(1.0) 
44(78.6%) 12(30.0%) 56(58.3%) 
12(21.4%) 21(52.5%) 33(34.4%) 25.790 < 0.001 













Loss of libido 
I used to cry, but now I can't, though I want 
I am no more irritated 
I get irritated easily than I used to 
I get irritated all the time now 
I have not lost interest in people 
I am less interested in other 
I have lost most of interest in people 
I have lost all of my interest in people 
I make decision as I ever could 
I put off making decisions 
I have greater difficult in making decisions 
I don't feel any worse 
I am worried I am looking old 
I feel permanent changes in my appearance 
I believe I look ugly 
I can work out as before 
It takes extra effort to work 
I have to push myself very hard 
I can't do any work at all 
I can sleep as usual 
I don't sleep as usual 
I wake up l-2h before time, hard to sleep 
I wake up several hours before, hard to sleep 
I don't get any more tired 
I get more tired 
I get tired from doing anything 
I am too tired to do anything 
My appetite is no worse 
My appetite is not as good as it used to 
My appetite is much worse 
I have no appetite at all 
I haven't lost much weight 
I have lost more than 5 pounds 
I am no more worried about my health 
I am worried about physical problems 
I am worried that I can't think of much else 
I am so worried that I can't think about anything 
I have not noticed any change in interest in sex 
I am less interested in sex than I used to 
I am much less interested in sex now 
I have lost interest in sex completely 
0(0.0%) 1(2.5%) 1(1.0%) 
48(85.7%) 17(42.5%) 65(67.7%) 
7(12.5%) 15(37.5%) 22(22.9%) 21.056 < 0.001 
1(1.8%) 8(20.0%) 9(9.4%) 
42(75.0%) 17(42.5%) 59(61.5%) 
14(25.0%) 12(30.0%) 26(27.0%) 19.626 < 0.001 
0(0.0%) 10(25.0%) 10(10.4%) 
0(0.0%) 1(2.5%) 1(1.0%) 
51(91.1%) 21(52.5%) 72(75.0%) 
5(8.9%) 13(32.5%) 18(18.8%) 19.943 < 0.001 
0(0.0%) 6(15.0%) 6(6.3%) 
43(76.8%) 18(45.0%) 61(63.5%) 
6(10.7%) 6(15.0%) 12(12.5%) 11.817 0.08 
7(12.5%) 15(37.5%) 22(22.9%) 
0(0.0%) 1(2.5%) 1(1.0%) 
38(67.9%) 10(25.0%) 48(50.0%) 
17(30.4%) 23(57.5%) 40(41.7%) 19.685 < 0.001 
1(1.8%) 6(15.0%) 7(7.3%) 
0(0.0%) 1(2.5%) 1(1.0%) 
42(75.0%) 19(47.5%) 61(63.5%) 
14(25.0%) 10(25.0%) 24(25.0%) 18.177 < 0.001 
0(0.0%) 3(7.5%) 3(3.1%) 
0. (0.0%) 8(20.0%) 8(8.3%) 
18(32.1%) 3(7.5%) 21(21.9%) 
36(64.3%) 30(75.0%) 66(68.8%) 12.218 0.007 
2(3.6%) 5(12.5%) 7(7.3%) 
0(0.0%) 2(5.0%) 2(2.1%) 
48(85.7%) 17(42.5%) 65(67.7%) 
8(14.3%) 13(32.5%) 21(21.9%) 23.974 < 0.001 
0(0.0%) 9(22.5%) 9(9.4%) 
0(0.0%) 1(2.5%) 1(1.0%) 
45(80.4%) 29(72.5%) 74(77.1%) 0.815 0.367 
11(19.6%) 11(27.5%) 22(22.9%) 
42(75.0%) 9(22.5%) 51(53.1%) 
12(21.4%) 20(50.0%) 32(33.3%) 21.192 < 0.001 
2(3.6%) 10(25.0%) 40(41.7%) 
0(0.0%) 1(2.5%) 1(1.0%) 
30(53.6%) 10(25.0%) 40(41.7%) 
10(17.9%) 6(15.0%) 16(16.7%) 10.283 0.016 
8(14.3%) 13(32.5%) 21(21.9%) 
8(14.3%) 11(27.5%) 19(19.8%) 
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4.6 Relationship between socio-demographic factors and depression 
in people living with HIV/AIDS 
The relationship between socio-demographic factors and depression was tested in 
different steps. First each selected socio-demographic factor (age of respondents, gender, 
marital status, socioeconomic status, family and social support and past psychiatric 
history) was tested for its relationship with depression using cross tabulation, and 
Pearson's chi-square analysis. Secondly, the socio-demographic factors that showed a 
trend of relationship with depression were assessed using the logistic regression to assess 
the likelihood of each factor being associated with depression whilst controlling for 
confounders. 
4.6.1 Cross tabulations of relationship between socio-demographic factors and 
depression 
4.6.1.1 Relationship between age of respondents and depression 
Increase in age tended to be associated with being depressed. People aged between 20 
and 30 were less likely to be depressed (25%) than people aged between 42 and 52 year 
old (50%). However, this tendency changed in people between the ages of 53 and 63 
(28.6%). Despite this trend, the results of the Pearson's chi-square indicated that this 
association was not statistically significant. The value of the Pearson's chi-square was 
3.3532 with ap value of {p- 0.340) as shown in table 4.5. 































4.6.1.2 Relationship between gender of respondents and depression 
Of the total male sample (n=29), 21 (72.4%) were not depressed, and 8 (27.6%) were 
depressed. On the other hand, of the total number of female in the study (n=67), 35% 
were not depressed while 32 (47.8%) were depressed. 
Cross tabulation was done on the relationship between gender and depression. The results 
of this showed that out of 40 respondents who scored depressed, women were more 
likely to be depressed with a proportion of 32 (47.8%) than men 8 (27.6%). This is shown 
in table 4.6. 
A Pearson's chi-square test was performed to test if this relationship was statistically 
significant. The results indicated that there was a borderline not statistically significant 
relationship, with females being more likely to be depressed than males (Pearson's chi-
square value of 3.389 and ap = 0.066). 






















4.6.1.3 Relationship between marital status and depression 
The majority of the sample size (n=40) were married. Amongst the married respondents, 
29 (72.5%o) were not depressed and 11 (27.5%) were depressed. The proportion of 
widowed respondents was 27, and 16 of them (59.3%) scored depressed, against 11 
(40.7%) who scored not depressed. Of the 10 respondents who were single, 7 (70.0%) 
were not depressed and 3 (30.0%) were depressed. 8 divorced respondents (n=14) were 
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not depressed whereas 6 (42.9%) were depressed. Very few respondents (5) were living 
in a cohabitating relation, and amongst them, 4 (80%) were depressed, whereas only 1 
(20%) was not depressed. 
A cross tabulation was done to assess the relationship between the relationship status and 
depression score. The results indicated that respondents who were living in cohabitation, 
who were widowed and who were divorced, were more likely to be depressed (80%, 
59.3% and 42.9% respectively) than those who were married and who were single 
(27.5% and 30.0% respectively). 
A Pearson's chi-square was performed to test the level of significance of this relationship. 
The test showed a %2 value of 10.332 and a p value of (p=0.035) which is statistically 
significant. Thus, there is a relationship between marital status and depression (p=0.035), 
in which those who are cohabitating, widowed and divorced were more likely to be 
depressed than those who are married. This is illustrated in table 4.7. 









Depression Total x Value P Value 
Not Depressed 
depressed 
7 (70.0%) 3 (30.0% 10 (100.0%) 
29(72.5%) 11(27.5%) 40(100.0%) 10.332 0.035 
8 (57.1%) 6 (42.90%) 14 (100.0%) 
1 (20.0%) 4 (80.0%) 5 (100.0%) 
11(40.7%) 16(59.3%) 27(100.0%) 
56 (58.3%) 40 (41.7%) 96 (100.0%) 
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4.6.1.4 Relationship between employment, socioeconomic status and living 
arrangement and depression 
Socioeconomic status was assessed in relation to depression. Respondents were asked to 
rate the amount of money they were able to afford for their daily living, in terms of less 
than 250 Rwandan Franc (Frw) or more than 250 Frw. Employment status was assessed 
in terms of respondents being employed or not being employed. Respondents were also 
asked to state whom they live with, either living with family, with friends or living alone. 
The cross tabulation showed a trend on the amount of money earned for daily living with 
the depression score. Respondents who earned less than 250 Frw. per day were more 
likely to be depressed (47.6%) compared to those who earned more than 250 Frw. 
(37.0%). However, the Pearson's chi-square analysis indicated a %2 value of 1.088 and a 
p value of (p=0.297) which is not significant, thus indicating that there is no statistically 
significant relationship between socioeconomic status and depression. 
Employment status was related to depression, where respondents who were not employed 
(27) tended to be more depressed (45.8%) than those who were employed (13, 35.1%). 
Again, the Pearson's chi-square analysis indicated a %2 value of 1.057 and a non-
significant p value (p=0.304), suggesting that employment was not statistically 
associated with depression. 
Although living alone was more likely to be associated with depression (50.0%) than 
living with family (36.5%) in cross tabulation analysis, this difference was not 
statistically significant in Pearson's chi-square analysis, with a y2 value of 3.004 and a 
(p=0.22). These values are indicated in table 4.8. 
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Table 4.8 Relationship between employment, economic status and living 










Less than 250 










24(64.9%) 13(35.1%) 37(100.0%) 1.057 0.304 
32 (54.2%) 27 (45.8%) 59 (100.0%) 
22 (52.4%) 20 (47.6%) 42 (100.0%) 
34(63.0%) 20(37.0%) 54(100.0%) 1-088 0.297 
40 (63.5%) 23 (36.5%) 63 (100.0%) 
3.004 0.223 
0 (0.0%) 1 (100.0%) 1 (100.0%) 
16 (50.0%) 16 (50.0%) 32 (100.0%) 
4.6.1.5 Relationship between level of satisfaction with family and social 
support and depression 
The level of satisfaction was assessed in terms of how satisfied respondents were with the 
support from family, from neighbors and friends, from other social networks and from 
other people living with HIV/AIDS. All these supports were added together to make an 
overall support score of 20. The minimum support score was 0 and the maximum was 19, 
with a mean of 11.80, and a standard deviation (SD=3.897). The mean score among 
depressed respondents was less (10.70) compared to that of non-depressed respondents 
(mean score of 12.60), with a mean difference of 1.900. Thus, the less support score, the 
more likely respondents were to be depressed and the greater support score, the less 
likely respondents were to be depressed. The t-test for independent sample test was 
performed to assess the relationship between the levels of support score and depression. 
The reason that a parametric test was used here is because the dependant variable was not 
significantly skewed and that the test was robust to departure from normality. The results 
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confirmed that support was significantly associated with scoring for depression, with a 
significance p of 0.018, a mean difference of 1.900, a standard difference error of 0.790 a 
95% confidence interval of this difference ranging between 0.332 and 3.468. Thus the 
more support received, the less likely the person is to be depressed. This is illustrated in 
table 4.9. 
Table 4.9 Relationship between level of satisfaction with support and depression 
Support score 








95% confidence interval 





4.6.1.6 Relationship between past personal and family psychiatric history with 
depression 
None of the respondents recorded any past psychiatric history before knowing his/her 
HIV status. Two of the respondents were treated for psychiatric disorders after they 
discovered their HIV/AIDS status and therefore they were not recorded. For the total 
sample of respondents, only 14 had a psychiatric history in their family against 82 who 
had not a family psychiatric history. For those respondents who had past family 
psychiatric history, 9 (64.3%) did not score depressed and 5(35.7%) scored depression. 
Comparing those who have a family psychiatric history with those who did not, only 5 
(35.7%) scored depression compared to 35 (42.7%) who did not. On Pearson's chi-square 
analysis, this also was not statistically significant (p=0.625). Therefore, this indicated 
that there is no relationship between having a past family psychiatric history and scoring 
for depression. This is illustrated in table 4.10. 
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Table 4.10 Family psychiatric history and depression 
History of 
psychiatric 








9 (64.3%) 5 (35.7%) 14 (100.0%) 
47(57.3%) 35(42.7%) 82(100.0%) 0.239 0.625 
56(58.3%) 40(41.7%) 96(100.0%) 
4.6.2 Logistic regression of relationship between socio-demographic factors and 
depression 
Logistic regression was performed to assess the association of different socio-
demographic factors for the likelihood that respondents would score positive to 
depression. Socio-demographic variables which were found to have a relationship with 
depression score or were statistically significant on Pearson's chi-square analysis were 
further tested for their relationship with depression. The independent variables entered in 
the logistic regression model were gender, marital status and the level of support score. 
As shown in table 4.11, gender and level of support were the only variables that remained 
in association with depression in the logistic regression model. Being a female was 
significantly associated with depression (p=0.047), recording an Odd Ratio of 2.712. This 
indicates that female participants were 2.7 times more likely to be depressed than males, 
with a Confidence Interval of 95%, ranging from 1.014 to 7.252. 
On the other hand, the total score of family, social and friend support was significantly 
associated with scoring positive to depression (p=0.018). The Odd Ratio for this value 
was however 0.868, ranging from 0.772 to 0.976. This indicates that the more support the 
participants received from family, social network and friends the less likely they were to 
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be depressed. Expressed in other words, an increase in social support by one unit 
decreases the likelihood of depression by 13.2%. 
The variable marital status lost its significance in the logistic regression model, possibly 
due to controlling for the confounding effect of support score. The findings showed a p 
value of (p=0.223) which is not statistically significant. This is illustrated in table 4.11. 
Thus, the results of the final logistic regression model showed that gender and level of 
satisfaction with received support were significantly associated with depression score (p= 
0.047 andp=0.018) respectively, taken into account all other socio-demographic factors 
that were studied. 
Table 4.11 Logistic regression of relationship between demographic factors and 




and social support 
Constant 
B P Value Odds Ratio 95%Confidence 
Interval (CI) 
Lower Upper 
0.998 0.047 2.712 1.014 7.252 
-0.142 0.018 0.868 0.772 0.976 
0.627 0.419 1.873 
This answers objective three of this study which was to assess the relationship between 
socio-demographic variables and depression among people living with HIV/AIDS 
attending a primary health care center in Kigali. 
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4.7 Relationship between HIV medical related information and 
Depression 
The relationship between medical related information with depression was also assessed 
in two different ways. Firstly, the relationship between medical related independent 
variables and depression were analyzed using cross tabulation, chi-square Pearson 
analysis. Secondly, variables which were found to be associated with depression were 
entered in the logistic regression model. 
4.7.1 Cross tabulations of relationship between medical information and 
depression score 
4.7.1.1 Relationship between the duration of known HIV/AIDS status and 
depression 
The relationship between the duration of time since respondents have known their HIV 
status and the likelihood of scoring for depression was assessed using cross tabulation. 
The results showed a slight difference in mean years (-0.544) between scoring depression 
and the duration of time since respondents have known their HIV status. Those who have 
known their HIV status with a mean duration of 4.98 years were less likely to be 
depressed than those who knew it within a mean of 5.53 years. A T-test for independent 
sample test was performed to test if this difference was statistically different. 
The results of the t test confirmed that there is no relationship between duration of time 
of knowing the HIV status and depression, with a p value of 0.371, a mean difference of-
0.544, a standard error difference of 0.606 and a CI ranging from -1.748- 0.659, thus 
excluding any significant statistical relationship. 
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Table 4.12 Relationship between duration of known HIV and depression 
Duration of time 
since known HIV 









95% confidence interval 





4.7.1.2 Relationship between the number of visits and having been admitted 
to the hospital and depression 
The number of visit to the hospital within the last month was assessed using categories 
such as has never been to the hospital, has been to the hospital once and has been to the 
hospital more than once. The results from the cross tabulation indicated that the number 
of visits to the hospital was associated with depression. As indicated in table 4.13, 
respondents who visited the hospital more than once (n=7) and those who visited the 
hospital once (n=9) were more likely to score depression (70.0% and 64.3% respectively) 
than respondents who never visited the hospital (32.4%). 
The Pearson's chi-square confirmed this relationship. It was found that the number of 
visits to the hospital was statistically significantly associated with depression, with a chi-
square value of 8.785 and a (p=0.012). Thus, the more the respondents visited the 
hospital, the more likely they are to score depression. This is illustrated in table 4.13 
below. However, having been admitted to the hospital in the last month was not 
statistically associated with depression, with a (p=0.158). 
72 
















48 (67.6%) 23 (32.4%) 71(100.0%) 
5 (35.7%) 9 (64.3%) 14 (100.0%) 
3(30.0%) 7(70.0%) 10(100.0%) 8.785 0.012 
1 (25.0%) 3 (75.0%) 4 (100.0%) 
55(60.4%) 36(39.6) 91(100.0%) 1.989 0.158 
4.7.1.3 Relationship between the presence of HIV/AIDS related symptoms 
and depression 
HIV/AIDS related symptoms such as unexplained weight loss, recurrent respiratory 
infection, recurrent oral ulceration and chronic diarrhea were assessed. Respondents were 
given an option of naming other HIV/AIDS related symptoms they may have presented 
with. The main other symptoms that were given by respondents were persistent 
headaches, forgetfulness, urinary infection, tuberculosis, neurological pain and abdominal 
pain. 
The findings of the cross tabulation analysis showed that overall; having HIV-related 
symptoms was associated with scoring positive to depression. Of the total number (n=15) 
of respondents who suffered recurrent respiratory infection, 10 (66.7%) scored 
depression, while 5 (33.3%) were not depressed. Again, of 11 respondents who presented 
other HIV-related symptoms such as persistent headaches, forgetfulness, urinary 
infection, tuberculosis, neurological pain and abdominal pain, 10 (90.9%) were 
depressed, whereas only 1 (9.1%) was not depressed. Of the 20 respondents who 
presented unexplained weight loss, 10 (50.0%) were depressed, and 10 (50.0%) were not 
depressed. Of the 4 respondents who presented recurrent oral ulceration, 3 (75.0%) were 
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depressed and 2 (25.0 %) were not. Also, the all respondents (2) who presented chronic 
diarrhea were depressed. More than half of respondents (55) did not present any 
symptoms related to HIV in a month prior to data collection. Of those who did not have 
symptoms, the majority, 40 (72.7%) were not depressed whereas 15 (27.3%) were 
depressed. 
The Pearson's chi-square test was performed to assess the significance of the relationship 
between presence of HIV related symptoms and depression. The results showed that 
having presented recurrent respiratory infection was statistically associated with 
depression, with a %2 value of 4.571 and a p value of (p=0.033). Further, having 
presented other HIV-related symptoms such as persistent headaches, forgetfulness, 
urinary infection, tuberculosis, neurological and abdominal pain was statistically 
associated with depression, with a p value of (p=0.001) on Fisher's exact test. On the 
other hand, not having presented any symptoms related to HIV/AIDS was a protective 
factor to depression, with a statistically significant p value of (p=0.001). Thus, having 
presented HIV related symptoms is strongly associated with depression. This is illustrated 
in table 4.14. 
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40 (72.7 %) 
10 (50.0 %) 
5 (33.3 %) 
1 (25.0 %) 
0(0.0%) 
1 (9.1 %) 
Depressed 
15 (27.3% 
10 (50.0 %) 
10 (66.7 %) 
3 (75.0 %) 
2(100.0%) 























4.7.1.4 Relationship between number of CD4 count and depression 
The numbers of CD4 counts were collected, either through self report information for 
those patients who could easily remember their CD4 measures, or through patients' files 
for those who were unable to remember. The most recent CD4 measurement was 
recorded. Five respondents (5.2% of the total sample) did not provide their CD4 and their 
file codes. The researcher was therefore not able to retrieve their files to check for them. 
These were considered missing values and the total number of respondents was 
considered to be 91. The majority of the respondents, 70 (n=91), had CD4 counts greater 
than or equal to 250, and the remaining 21 had CD4 counts less than 250. 
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The results of the cross tabulation showed that depression was highest (57.1 %) among 
respondents who had less than 250 CD4 counts compared to those who were not 
depressed (42.9 %). More respondents (64.3%) who had CD4 counts greater than 250 
were not depressed compared with those who were depressed (35.7%), but this difference 
was not statistically significant (p=0.080). This is illustrated in table 4.15. 









9(42.9%) 12(57.1%) 21(100%) 3.074 0.080 
45 (64.3 %) 25 (35.7 %) 70 (100.0%) 
54 (59.3%) 37 (40.7%) 91 (100.0%) 
4.7.2 Logistic regression of medical related information associated with depression 
Logistic regression was performed to assess the association of different medical related 
factors with the likelihood of scoring positive to depression, while controlling for 
confounders. The independent variables entered in the logistic regression model of six 
steps were number of CD4 counts, presence of HIV related symptoms, number of visits 
to the hospital, admission in the hospital and time known HIV status. Only the last of six 
steps of logistic regression model is presented in table 4.16. 
As shown in the table 4.16, the presence of HIV related symptoms was statistically 
associated with scoring positive to depression. Presenting with other HIV/AIDS related 
symptoms such as persistent headache, urinary infection, neurological and abdominal 
pain, was significantly associated with depression, with a p value of (0.005) and an Odd 
Ratio of (OR=22.011), with a Confidence Interval of (2.209-193.130). Thus, respondents 
who presented other HIV/AIDS related symptoms were 22.01 times more likely to score 
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depression than respondents who did not have those symptoms. Also, having CD4 counts 
less than 250 was statistically associated with depression, recording a p value of 
(p=0.054) and (OR=2.915, O0.981-8.657). Thus respondents who had less than 250 
CD4 cell counts were 2.915 times more likely to be depressed than those who had more 
than 250 CD4 counts. 
Variable recurrent respiratory infection was significantly associated with depression in 
chi-square but lost its significance in logistic regression, with a p value (p=0.066) which 
is borderline not statistically significant. The variable visit to hospital which was 
significantly associated with depression in Pearson's chi-square also lost its significance 
in logistic regression. 
Thus, the results of the final logistic regression model indicated that having taken into 
consideration all the medical related factors that were studied; presenting with HIV 
related symptoms and having CD4 counts of less than 250 were statistically associated 
with depression. 
Table 4.16 Logistic regression of relationship between medical related factors 




Other HIV related symptoms 
CD4 <250 
Constant 
B Significance Odds Ratio 95%Confidence 
P Interval (CI) 
Lower Upper 
1212 0.066 3.362 0.924 12.223 
3.092 0.005 22.011 2.509 193.130 
1.070 0.054 2.915 0.981 8.657 
-1.189 <0.001 0.305 
This answers objective four of this study which was to assess the relationship between 
HrV related medical variables and depression among people living with HIV/AIDS 
attending a primary health care center in Kigali. 
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4.8 Conclusion 
In this chapter, the researcher analyzed data by means of SPSS for window version 15 
and by using different statistical tests such as frequencies, standards deviation, cross 
tabulation analysis and Pearson's chi-square analysis, and t test for independent test. 
Logistic regression was used to test the relationship between independent variables in the 
study and depression. A p value of less than 0.05 was considered as statistically 
significant. 
Overall, the findings suggest that depressive symptoms are very high among HIV-
infected patients in this study, with a prevalence of 41.7%. The most frequent depressive 
symptoms presented in this study were pessimism, fatigability, sad mood; lack of 
satisfaction, somatic preoccupation, loss of libido, crying spells, work inhibition, 
irritability, social withdrawal and loss of appetite. 
Having taken into consideration all other socio-demographic factors that were studied, 
being a female (p=0.047, OR=2.712, 95% CI =1.014-7.252) was associated with high 
risk of depression, and high support from family was a protector factor to scoring for 
depression (p=0.018, OR=0.868, 95% CI=0.772-0.976). 
Considering all the HIV-related medical factors that were studied, presenting with many 
HIV-related symptoms in the month prior to data collection (p=0.005, OR=22.011, 95% 
CI=2.209-193.130), and having a CD4 count of less than 250 (p=0.054, OR=2.915, 95% 
0=0.981-8.657) were strong predictors of depression. 
The next chapter contains a discussion of the findings, limitations of the study and 
recommendations for mental health care in general and for psychiatric nursing practice at 
the primary health care centre. 
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Chapter Five 
Discussion of findings, conclusion and 
recommendations 
5.1 Introduction 
The purpose of this study was to explore the prevalence of depression and to analyze the 
factors associated with depression among HIV infected patients attending a Primary 
Health Care Centre in Kigali (see page 7 section 1.4 for these objectives). 
In this chapter, the major findings of the study will be discussed in relation to the 
conceptual framework. This discussion will be supported by relevant literature. This 
chapter also discusses the limitations of this study and outlines a number of 
recommendations for health organizations and for nursing education, practice and 
research. 
HIV medical related factors (CD4 count, number of HIV-related symptoms, the time of 
known HIV status and previous admission to hospital) were taken to represent increased 
biological vulnerability and the sociodemographic factors (age, gender, marital status, 
employment, economic status, social support and past history of psychiatric disorders) 
were taken to represent personal and social protective and/or vulnerability factors. 
According to the stress vulnerability model, the more biologically compromised the 
individual (low CD4 count, progression towards AIDS, frequent admission to hospital), 
and the less the presence and action of protective personal and social factors, the more 
likely the person is to developing serious depressive symptoms. Likewise, the more 
biologically compromised the individual, and the greater the presence and action of 
protective personal and social factors, the less likely the person is to developing serious 
depressive symptoms. (Adewuya et al., 2007; Berger-Greenstein et al., 2007; Bing et al., 
2001; Farber & McDaniel, 2002; Kaharuza et al., 2006; Komiti et al. 2003; Leserman et 
al., 2000; Uys & Middleton, 2004). 
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5.2 Personal and social protective factors in the sample 
Ninety- six people living with HIV/AIDS attending a selected primary health care centre 
in Kigali constituted the sample size for this study. The mean age was 39.15 years, and a 
standard deviation (SD= 9.121), the age years ranged from 18 to 62. This suggests that 
the age of the sample was normally distributed. The sample was predominantly female 
(69.8%). This is in agreement with other studies to assess mental disorders and 
depression in people living with HIV in Africa, in (Uganda) and (South Africa) 
(Kaharuza et al., 2006; Freeman et al., 2008). The predominance of women in this sample 
can be justified in part by the high rate of women infected with HIV in Rwanda which is 
estimated to be significantly higher in women (3.6%) than in men (2.3%) (CNLS, 2009). 
More than half the sample was not employed (61.5%) and a little over two thirds of the 
sample were employed (38.5%). Under half of the sample in this study (43.8%) lives 
under the poverty line and 56.3% live above the poverty line. This is in line with the 
estimates of CNLS (2009) which states that around 20% of people living with HIV in 
Rwanda are not employed or working, and that HIV infected women are more likely to 
live in extreme poverty than men. 
The majority of the sample (41.7%) were married, 27 (28.1%) were widowed, 14 (14.6%) 
were divorced, 10 (10.4%) were single. More than half (65.6%) were living with their 
family, while 33.3% of the respondents lived alone. The minimum support score was 0 
and the maximum was 19, with a mean of 11.80 and a standard deviation (SD=3.897). 
This suggests that the majority of respondents were overall satisfied with their support 
from families, neighbours and friends, their other social networks and other people living 
with HIV/AIDS. This finding is potentially different from that reported by CNLS, (2009). 
This organization reported that in 2008, over 40% of people living with HIV have been 
excluded from a social gathering, over 50% have been insulted and over 20% have been 
physically assaulted. This finding may suggest that stigmatizing attitudes are not as 
prevalent. However, it is also possible that the exclusionary practices highlighted in the 
CNS study emanated from the wider social environment and not by people intimately or 
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even loosely connected with the infected person. Thus, further research is necessary to 
differentiate between perceived sources of social support (personal and structural) and 
degree of social stigma. 
The majority of the respondents were medically well, based on the CDC classification of 
system for HIV (www.cdc.gov ). Although there was a large variation in CD4 counts, the 
minimum CD4 count was 50, maximum 1034, with a mean of 380.97, and a standard 
deviation (SD= 193.396). More than half the sample (56.3%) did not present any 
symptoms related to their HIV status in the month prior to data collection while 42.7% 
presented with HIV related symptoms. The sample characteristics in this study are in line 
with a previous study done by Komiti et al. (2003) in a population of people living with 
HIV attending a primary care clinic. This study found that both CD4 counts measures and 
viral load counts indicated that the immune function of most participants in their study 
was at normal level. The explanation for the absence of HIV related symptoms among 
respondents in this study may be that the sample was selected from an outpatient health 
facility, which mainly receives patients who are generally medically well. 
5.3 Depression among people living with HIV/AIDS attending a 
primary health care center in Kigali 
From the conceptual framework point of view, the presence of psychiatric problems or 
symptoms is regarded as the outcome of the interaction between biological, social and 
personal vulnerability factors (Uys & Middleton, 2004). In this study, the prevalence of 
depression and the depressive symptom profile of people diagnosed with depression are 
the phenomena of interest. 
5.3.1 Prevalence of depression among people living with HTV7AIDS 
The prevalence of depression among people living with HIV/AIDS who participated in 
this study was 41.7%. The total of depressed participants is in the range between 31.83% 
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and 52.18% (CI of 95%). This means that almost a half of people living with HIV in the 
present study scored positive for depression, thus confirming that there is a high 
prevalence of depression among people living with HIV/AIDS attending a selected 
primary health care centre in Kigali. 
This prevalence of depression among people living with HIV in this study is closer to the 
prevalence of 53% for depression among youth heads of household in Rwanda (Boris et 
al., 2008). This rate is higher than the prevalence rate of depression in a group of 
Rwandans affected by genocide which was estimated to be around 15.5% (Bolton et al., 
2002) and higher than that of found among genocide widows (18.6%) (Hangengimana et 
al., 2003). On the other hand, the rate is significantly lower than the 81% prevalence for 
clinically significant depression among Rwandan HIV infected women on antiretroviral 
therapy (Cohen et al., 2008). The reasons for this difference between the prevalence of 
depression in this study and the prevalence in a study by Cohen et al. (2008) may have 
been caused by different factors. Firstly, these authors studied a cohort of Rwandan 
women who are both HIV positive and for the majority, rape survivors of the 1994 
genocide. These traumatic experiences (rape and an HIV/AIDS diagnosis) contributed 
significantly to increasing their risk for depression. In the second place, their study used 
the Center for Epidemiologic Studies Depression Scale and not the Beck Depression 
Inventory Scale to assess the prevalence of depression. Kalichman, Rompa and Cage 
(2000) compared the results of CESD and BDI scales and found that a number of people 
who scored depressed on the BDI were not depressed on the CESD, and a number of 
those who were depressed in CESD were not depressed in BDI. There was only a 55% 
concordance in depression among the two scales, which suggests that both scales can 
yield different scores. This underscores the need for further research to explore the 
commonalities and differences in the two scales, and how the results from the scales can 
be effectively used in clinical screening. 
The prevalence of depression in this study is similar to that found in a study done in 
Kenya to assess the psychiatric disorders among adults patients in general medical 
facilities. The study found that 42.3% of the total sample screened positive to mild, 
moderate or severe depression using BDI (Ndetei et al., 2009). A similar rate (47%) was 
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also found in a study done in Uganda to assess depression among HIV- infected adults 
undergoing antiretroviral eligibility screening (Kaharuza et al., 2006). 
However, the prevalence of depression in this study is higher than the prevalence of 
depression among people living with HIV in South Africa, which was found to be 
between 11% and 14% (Freeman et al., 2007; Myer et al., 2008). It is also higher than the 
prevalence rate of 19.4% - 22% found in American people living with HIV attending 
outpatient primary care clinics (Komiti et al., 2003; Morrison et al., 2002). 
The fact that the prevalence in this study is greater than that found in South African and 
American HIV-infected populations may suggest that depression among HIV-infected 
patients is higher in low income countries (such as Rwanda, Uganda, Kenya and 
Rwanda) (Cohen et al., 2008; Kaharuza et al., 2006; Ndetei et al., 2009.) than in upper-
middle income countries (such as South Africa,) Myer et al. (2008) and higher income 
countries (such as America) Morrisson et al. (2002). This underscores the importance of a 
comparative study of prevalence of depressive disorders among HIV-infected people 
across countries. 
5.3.2 Clinical profile of depression 
This study found that for the total sample (n=96), 27.1% respondents were mild to 
moderately depressed, 12.5% were moderately to severely depressed and 2.1% were 
severely depressed. This score profile of depression is similar to that found in a study by 
Kolaric et al. (2006). These authors found that of a sample of 80 HIV-infected Croatian 
patients, 20% (CI= 11% to 29%) scored moderate to severe depression (BDI >18) and 
5% (CI 0.3% to 9.7%) scored severe depression. However, the depression score in this 
study is marginally less severe than in Weiser et al. (2006) who found that 42% of their 
sample (n=239) in the United States scored mild to moderate depression and 14% scored 
severe depression. 
The most common depressive symptoms that were presented by depressed respondents in 
this study were pessimism and fatigability (37/40), followed by sad mood (36/40); lack of 
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satisfaction (35/40), somatic preoccupation (31/40), loss of libido (30/40), crying spells 
(29/40), work inhibition (28/40), irritability, social withdrawal and loss of appetite 
(23/40). In a study by Berger-Greenstein et al. (2006), most participants (74.1%) reported 
experiencing at least three or four vegetative symptoms such as insomnia, psychomotor 
retardation/agitation, fatigue/loss of energy and weight loss; 68% reported affective 
symptoms such as anhedonia and depressed mood; and 60% experienced cognitive 
symptoms such as thoughts of worthlessness, diminished ability to think or concentrate, 
and thoughts of death. 
Kalichman et al. (2000) have argued that the presence of somatic symptoms may cause 
the overscoring of depression in people affected by a medical condition. These authors 
maintain that using the Beck Depression Inventory Scale without removing the 
overlapping symptoms of HIV disease and somatic symptoms for depression can increase 
depression scores in symptomatic HIV positive persons. However, Weiser et al. (2006) 
found that the depression score in their study did not differ when they used the full Beck 
Depression Inventory Scale and when somatic symptoms were removed from the scale. 
Similarly, in a study by Kolaric et al. (2006), comparing the distribution of Beck 
Depression Inventory Scale scores without somatic symptoms yielded a similar result as 
when the full BDI was used. Kaharuza et al. (2006) also did not find any difference in the 
depression score among people infected with HIV/AIDS when they used the full 
Epidemiologic Studies Depression Scale and when they removed the somatic symptoms 
from the scale. 
Previous research assessing psychopathology, particularly affective disorders such as 
depression in African countries (Patel, Abas, Broadhead, Todd & Reeler, 2001; 
Tomlinson, Swartz, Kruger & Gureje, 2007), and in Rwanda (Hagengimana et al., 2002), 
have reported that affective disorders, particularly depression have different presentations 
across cultures, and that somatic presentations are frequent in these populations. For 
example, Patel et al. (2001) reported that depression in Zimbabwe presents mainly with 
multiple somatic complaints such as headaches and fatigue, and other symptoms related 
to the heart and the head. In the same way, in their study on manifestation of affective 
disorders in Sub-Saharan Africa, Tomlinson et al. (2007) found that affective disorders 
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present largely in somatic forms, which if not accounted for, may obscure the detection of 
depression. It should also be noted that the majority of respondents in this study (55%) 
were HIV asymptomatic. Thus, the probability is high that the symptoms of fatigue, 
reduced appetite and loss of energy were not present as an expression of the HIV/AIDS 
profile and therefore influenced the depression score as depressive symptoms and not 
than HIV/AIDS symptoms. 
5.4 Association between social-personal factors and depression in 
people living with fflV/AIDS 
Socio- personal factors which were studied in this study are age, gender, marital status, 
employment status, income, living arrangement, previous history of mental disorders and 
the level of satisfaction with social and family support. 
Overall, being a female, divorced, and widowed or cohabitating, with poor social and 
family support were found to be the social-personal factors that increased the risk of 
depression among people living with HIV/AIDS. 
The findings of this study suggest that both in univariate and multivariate analysis 
models, age of respondents (p=0.340), employment status (p=0.304), income (p=0.297) 
and living arrangement (p=0.223) were not associated with depression. These findings 
are in line with those in a study by Morrison et al. (2002) who found that age and income 
were not significantly correlated with psychiatric disorders. Similarly, Adewuya (2007) 
found no significant correlation between psychiatric disorders with age, sex, and socio-
economic status. However, unemployment and living alone were found to be 
significantly associated with the high prevalence of psychiatric disorders among people 
living with HIV/AIDS (Bing et al. 2001). The fact that employment and income were not 
significantly associated with depression in this study may in part be because participants 
in this study were selected from an urban primary health care centre situated in Kigali, 
the capital city of the country. This area is ranked the least affected province by poverty 
in Rwanda compared to the other remaining four provinces (NIS, 2007). 
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None of the participants in this study reported suffering from a mental disorder before 
knowing their HIV/AIDS status. Previous research has found that previous history of 
depressive disorders was a stronger predictor of scoring high rate of depressive disorders 
among people living with HIV/AIDS than with non-infected people (Komiti et al., 2003; 
Morrison et al., 2002). Only two respondents reported suffering from a mental health 
problem which developed after they learned of their HIV/AIDS status. This is in line with 
the findings of a study by Mello and Malbergier (2005) who found that a large proportion 
of women in their sample (48%) presented at least one depressive episode after being 
informed of their HIV diagnosis. The WHO Report (2008) stresses that most people 
suffer depression or other psychiatric disorders when trying to adjust to the impact of 
being infected and having to face the difficulties of living with a chronic life-threatening 
illness. For the few (14, n= 96) respondents who reported a family history of psychiatric 
disorders, the results of the cross tabulation and chi-square test did not show any 
significance relationship between family history and depression. This lack of association 
may be due to the low number of respondents who had family history of psychiatric 
disorders in this study. 
Marital status, particularly living in cohabitation, being a widow and a divorcee, were 
associated with scoring positive to depression than being married or single in univariate 
cross tabulation analysis in this study (p=0.035). This significance was reduced in 
multivariate logistic regression. This might have been due to controlling for the 
confounding effect of support score, thus, it is possible that those who are married get 
more support than those who are divorced, widowed or are living in cohabitation. In their 
study, Judd et al. (2003) found that being in an intimate relationship and living with one's 
partner lowered the risk of depression. 
The results of the multi-logistic regression have shown that gender and level of 
satisfaction with family and social support were significantly associated with depression, 
having taken into account other factors that were studied. Being a female was over 2 
times more likely to score positive to depression than being a male (OR=2.712, 95% 
CI= 1.014-7.252). A possible explanation for the higher rate of depression among females 
(47.8%) than males (27.6%) might have been due to the overrepresentation of females 
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(65/91) than males (29/91) in this study. Nevertheless, the female gender has been found 
to be associated with scoring positive to depression in other previous studies assessing 
depression in a population of HIV infected people (Israelski et al., 2007; Kaharuza et al., 
2006). Research on depression in the general population have also found that gender is 
significantly associated with depression with females being more likely to have 
depression than males (Riolo et al., 2005; Stein et al., 2008). Morrison et al. (2002) argue 
that the significant additional stressors that women living with HIV/AIDS face, in 
addition to their family and career roles, constitute a principal factor of vulnerability to 
depression. This is possibly the case in Rwanda, where the female gender is considered a 
vulnerable group, especially because a large number are rape survivors, are single heads 
of household in the absence of husbands who may have died or are imprisoned on charge 
of genocide. These are considered pre-existing traumatic experiences which make women 
especially vulnerable to depression in the context of HIV (Cohen et al., 2008). 
The findings of this study suggest that having more family and social support was a 
protective factor to scoring positive to depression (OR=0.868, 95% CI=0.772-0.976). 
This means that an increase in social support by one unit decreases the likelihood of 
depression by 13.2%. Conversely, a decrease in social support by one unit increases the 
likelihood of depression by 13.2%. Previous studies assessing factors associated with 
depression among HIV infected people have found that lack of social support constitutes 
a strong predictor to depression and to mental disorders among people living with HIV 
(Bing et al., 2001; Ingram, Jones, Fass, Neidig & Song, 1999; Judd et al., 2005; 
Leserman et al. 2000). In a study by Ingram et al. (1999), individuals living with HIV 
who reported receiving more unsupportive social interactions, mainly insensitivity, 
disconnecting and blaming interactions also reported being more depressed. Similarly, 
Prachakul, Grant and Keltner (2007) report that people living with HIV with less social 
support had more depressive symptoms. On the other hand, Leserman et al. (2000) state 
that the availability of social support, a sense of belonging or integration within a social 
network including primary partners, families, and/or friends and peers is associated with 
greater psychological adjustment in HIV/AIDS. A South African study found that people 
who had been part of a support group and who perceive themselves as having a 
supportive context were less likely to have a diagnosis of mental disorder than those who 
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never joined a support group and who felt discriminated or isolated by their family 
members and community (Freeman et al., 2007). On the same way, Mundell (2006) 
found that participating in a support group increased HIV infected women's self-esteem 
and offered them support and positive ways of coping with the infection. 
Social support is especially significant in African context, where people depend on their 
family support and social networks for social as well as economic survival (Mundell, 
2006). 
5.5 Association between biological vulnerability factors and 
depression in people living with HIV/AIDS 
HIV medical related factors that were studied in this research were time of known HIV 
status, number of visit and admission to hospital due to HIV, the presence of HIV-related 
symptoms and the CD4 counts measures. 
Overall, having lower CD4 counts, having visited the hospital more than once and having 
presented many HIV-related symptoms were the biological factors that increased 
vulnerability to depression among people living with HIV/AIDS. On the other hand, 
having high CD4 counts, fewer visits to hospital and few HIV-related symptoms were the 
biological factors that decreased the risk of depression. 
The duration of knowing HIV status was not statistically associated with depression (p= 
0.618). This is in line with the findings from other studies that the number of years of 
knowing HIV status is not associated with depression (Judd et al., 2003; Katz et al., 1996; 
Komiti et al., 2003). However, Myer et al., (2008) found that depressive episodes were 
more likely to be associated with short time since the HIV status is known. Having been 
admitted to hospital in the previous month before data collection was also not statistically 
associated with depression (p values 0.158). Adewayu et al. (2007) also found that 
previous hospitalization due to HIV/AIDS did not predict depression or other psychiatric 
disorders. The lack of significance in this study might be also explained by the fact that 
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there were very few respondents (4/96) who were admitted into hospital in the month 
prior to the data collection period to allow accurate cross tabulation with depression. 
CD4 cell count was significantly associated with scoring positive to depression, with 
those having less than 250 CD4 cell counts being almost 3 times at risk of depression 
than those who had CD4 counts more than 250. This corroborates the findings from 
previous studies which found that CD4 counts are a strong predictor to mental disorders 
(Katz et al., 1996; Moosa, Jeenah & Voster, 2005) and to depression in particular 
(Berger-Greenstein et al., 2007; Kaharuza et al., 2006). However, other studies have not 
found any statistically significant difference in CD4 counts with depression. Judd et al. 
(2005) found that HIV indicators such as number of years HIV seropositive, CD4 counts 
measures and viral load were not significantly correlated with depression. This is in 
agreement with Komiti et al. (2003) who found that immune function indicators such as 
number of CD4 counts, HIV RNA count, disease stage and duration of HIV illness did 
not have any significant association with depressive symptoms. Also, Freeman et al. 
(2008) have found in their study that CD4 counts were not significantly associated with 
mental disorders. 
Number of visits to hospitals (p=0.012) was significantly associated with depression in 
univariate analysis, with respondents who visited the hospital more than once being at 
risk of depression than those who did not visit the hospital, but this did not remain 
significant in multivariate analysis in this study. This might have been due to controlling 
for HIV-related symptoms, since it is these symptoms that motivated their frequent visits 
to hospital. 
The presence of HIV-related symptoms in previous month was strongly associated with 
depression in both models. Having presented other HIV/AIDS related symptoms, such as 
persistent headache, urinary infection, neurological and abdominal pain, was significantly 
associated with depression (p= 0.005; OR=22.011, 95% CI=2.209-193.130). Thus, 
respondents who presented other HIV/AIDS related symptoms were over 22 times more 
likely to score depression than respondents who did not have those symptoms. Not 
having presented any symptoms related to HIV/AIDS was a protective factor to 
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depression, with a statistically significant p value of (p=0.001). This confirms the 
findings of Bing et al., (2001), where HIV-related symptoms were associated with 
screening positive to psychiatric disorder, and the strength of the relationship increased 
with increasing HIV-related symptoms. This is in line with the findings of this study, 
since the more symptoms respondents presented with, the more their chances of 
screening positive to depression increased. Freeman et al. (2008) support that HIV related 
symptoms explain a deteriorating condition of one's health, which may be highly 
distressing compared to CD4 counts measures which are not tangible and visible. 
Overall, the findings of this study suggest that female gender, social support, HIV-related 
symptoms and CD4 counts less than 250 are the factors that are statistically significantly 
associated with depression, and this is in agreement with the findings by Katz et al. 
(1996). These authors found that overall, HIV related symptoms (p=0.001), low CD4 
counts (p=0.003) and social support (p=0.001) remained statistically significant as 
predictors of depression (Katz et al., 1996). 
5.6 Limitations of the study 
This study has some limitations, mainly related to the sample and the use of a 
standardized scale to measure depression. 
The sample used in this study is selected from a single health center patient population 
and therefore the results may not be representative and generalizable to the general 
population of people living with HIV/AIDS in Rwanda. Although the sample size was 
calculated according to an acceptable formula, it could have been bigger to allow for the 
statistical tests to yield the level of significance between some variables and scoring 
depression. Nevertheless, despite these limitations related to the sample size, the results 
from this study are informative in a way that they give a prevalence of depression and 
associated factors among HIV infected people in a context of a selected primary health 
care centre in Rwanda, which adds to a limited body of knowledge in this area and may 
serve as foundation for future representative researches of the same issues. 
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Generally, the use of standardized self-report scales has been criticized for focusing on 
symptom severity by using cutoff scores rather than relying on clinical interview data 
(Sheeran & Zimmerman, 2002).The criticism may therefore have more to do with the 
issue that using a standardized scale does not always allow for an in-depth exploratory 
conversation as does a clinical interview. According to Sheeran & Zimmerman, 2002), 
the primary function of a standardized scale is symptoms screening, preparing as a 
prelude to in-depth interviewing in the clinical situation. 
The reliability of BDI has been extensively validated in similar population and in similar 
context and found to be reliable. Furthermore, the reliability of Beck Depression 
Inventory was validated in this study and a Cronbach's alpha of 0.83 was found. 
Due to time and resource constraints, this research did not screen for other common 
psychiatric disorders. The choice of depression was motivated by the fact that it is the 
most common psychiatric disorder affecting people living with HIV in the literature. 
However, it should be noted that people living with HIV infections may suffer from other 
range of psychiatric disorders which need to be screened and treated. Research assessing 
the prevalence of other psychiatric disorders affecting people living with HIV/AIDS is 
needed. 
Some HIV medical indicators such as viral load measures and types of antiretroviral 
treatment used by patients were not assessed in this study, yet have been found to be 
predictors of depression in previous studies (Morrison et al., 2002; Myer et al., 2008). 
Time and resources constraints mitigated against their inclusion and it is recommended 
that future research consider all these HIV related medical factors and how they increase 
vulnerability to depression. 
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5.7 Recommendations 
The need for early screening of depression in this population is critical. Therefore, this 
section begins with a brief description of what such a screening tool might consider and 
how it might be structured, by drawing on the findings from this study. Thereafter, 
recommendations for HIV/AIDS policy makers, for nursing practice, nursing education 
and nursing and public health research have been developed. 
5.7.1 Clinical screening tool for depression, based on the major findings of this study 
The tool should comprise an assessment of both symptoms of depression commonly 
presented by patients with HIV/AIDS, and assess the vulnerability factors, as well as 
protective factors 
5.7.1.1 Common symptoms of depression 
It has been found in this study that the most common depressive symptoms among 
respondents were pessimism, fatigability, sad mood, lack of satisfaction, somatic 
preoccupation, loss of libido, crying spells, work inhibition, irritability, social withdrawal 
and loss of appetite. Although suicide did not reach a statistical significance, six of the 
respondents reported having had thoughts of self-harm and two respondents would like to 
kill themselves if they had a chance. 
The screening tool should contain the above mentioned common symptoms, and the 
presence of them among HIV infected people attending the health centre should require a 
thorough assessment. 
5.7.1.2 Vulnerability factors 
It was found in this study that being female, having lack of social support, presenting 
different HIV-related symptoms and having CD4 counts fewer than 250 constitute factors 
of vulnerability to depression among people living with HIV/AIDS in this study. 
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HIV-infected patients who are found to have one of the above vulnerability factors 
should be considered as at risk of depression and undergo screening assessment. 
5.7.1.3 Protective factors 
Being married, having enough social support, having greater CD4 counts, few HIV-
related symptoms and fewer visits to hospital were found to be protective factors to 
depression. These factors need to be highlighted in the screening tool to save the clinician 
to reinforce and to focus on them while designing a plan of care for patients. 
5.7.1.4 Risk assessment tool 
Factors to consider 
1. Depressive symptoms 
Dou you feel sad, depressed? 
Do you feel discouraged about the future? 
Do you have thoughts of killing yourself? 
Are you dissatisfied with everything? 
Do you cry more often? 
Do you feel irritated more often? 
Have you lost interest in other people 
Do you push yourself to get something done? 
Do you get tired more easily? 
Did you lose your appetite? 
Did you lose interest in sex? 
Do you feel worried about your health than usual? 
Yes No 
If at least four answers to the above questions are yes, explore risk factors 
2. Risk factors for depression among HIV-infected patients 
Female 
Poor social support 
HIV-related symptoms 
Visits to hospital in previous month 
CD4 counts less than 250 
If risk factors are present, consider the patient as being at risk for depression 
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5.7.2 Policy-makers 
Mental health and HIV/AIDS services should be integrated and routine screening a 
matter of policy. 
It is recommended that the National Aids Control Commission (CNLS) and the Center 
for Treatment and Research on AIDS (TRAC) make the integration of mental health 
services into existing HIV services in the country a priority. WHO (2008) report that this 
integration constitutes an opportunity to improve the health of people living with 
HIV/AIDS. The prevalence of depression among people living with HIV/AIDS in this 
study (almost half the sample; 41.7%) shows that there is a high prevalence of depression 
(and there may be other mental health problems) among people living with HIV/AIDS. 
Yet, previous studies have shown that depression and other mental disorder often go 
undetected and subsequently untreated in HIV care settings (Israelski et al., 2007; 
Petrushkin et al., 2005). CNLS should therefore include the policy on integration of 
mental health in HIV/AIDS services in their AIDS strategic plan. The already started 
initiative of integrating HIV services in one psychiatric hospital should be reinforced and 
expanded to other mental health services in the country. The results of this and previous 
studies underscore the need for integrating mental health in HIV/AIDS services and a 
systematic screening of mental disorders among people living with HIV/AIDS. TRAC 
should conduct training on recognizing; diagnosing and treating depression and other 
mental disorders among people living with HIV/AIDS for all health professionals who 
work in HIV/AIDS services. The World Health Organization (2005) has outlined some 
modules that can be used to achieve this. 
Systematic screening can be achieved through the use of quick and easy to administer 
screening tools such as the BDI and Epidemiological Depression Scale. All health 
professionals involved in consultation can be trained on how to use these screening tools, 
and patients who screen positively can then be referred for further, in-depth assessment 
(Valente, 2003). HIV services at district level should collaborate with mental health 
services available in district hospitals of the country through regular supervision, and 
difficult cases can be referred for mental health follow-up. A risk assessment tool based 
on the key findings of this study has been provided (section 5.7.14) and can routinely 
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serve the primary care clinician to assess the risk of depression before administering 
more structured screening scales. 
5.7.3 Nursing practice 
It is recommended that the primary health care centre conduct in-service training with 
their health professionals, particularly nurses since are the group which consults with 
HIV infected patients about how to manage their health status, treatment regimes and 
psychosocial issues. Systematic training for this group in mental health screening should 
be a matter of policy (addressed above) and routine application in each consultation. 
Nurses should include mental disorders and depression in their education to patients 
living with HIV and their family, with particular emphasis on how to recognize 
symptoms of depression, how to report them and practical measures for increasing the 
protective factors in their lives and for decreasing biological vulnerability. The stress-
vulnerability framework would ensure that the approach is holistic and in keeping with 
the patients needs and the nursing mandate. 
Evidence has shown that that support groups have been successful in dealing with 
psychosocial problems related to HIV in other African countries (Bolton et al., 2003; 
Freeman et al., 2007). This is therefore an important protective coping strategy which 
nurses could include in their repertoire of interventions. Group work also has the 
advantage over individual work in that support is simultaneously provided for and 
generated through the coming together of a larger number of people. All patients living 
with HIV/AIDS should at least participate in support groups during their course of 
treatment and this participation should be prescribed and adhered to as are the biological 
treatments. Furthermore, stigma-reducing and thus, support enhancing programs could be 
developed to advocate for the support of people living with HIV/AIDS and their families 
through concerted primary health care awareness campaign. 
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5.7.4 Nursing and public health research 
This study did not assess the prevalence of all common psychiatric disorders among 
people living with HIV/AIDS and yet this information is important for health system 
planning, resource allocation and targeted primary health intervention programmes. 
Research in this area would be valuable for strengthening health systems capacity to 
respond to twin health burden of HIV/AIDS and mental illness. A larger sample based on 
a national survey and taking into account different sites can help to generate 
generalizable information about the prevalence of mental disorders among HIV infected 
people in Rwanda. 
Furthermore, some important HIV medical related information such as viral load and 
antiretroviral treatment and how they are associated with depression or other mental 
disorders were not assessed in this study. Knowledge about these relationships is 
important for supporting medication and treatment adherence in both HIV/AIDS and 
mental illness and for understanding both the biological and psychological dimensions of 
both disorders. This is especially important for psychiatric nursing which defines itself as 
a holistic, person-oriented caring process. In this respect, psychiatric nursing needs to 
develop a more robust body of knowledge about how patients experience and manage 
these disorders and the impact of specific targeted nursing actions in strengthening 
protective factors and reducing the impact of vulnerability factors in supporting the 
mental health status of patients living with HIV/AIDS. 
5.7.5 Nursing and health professional education 
HIV/AIDS has been introduced as a compulsory course in all higher education learning 
programs in Rwanda. The content of this course focuses on HIV/AIDS in general but it is 
this researcher's opinion that the mental health aspects of HIV/AIDS should be integrated 
into the curriculum, especially in those institutions where nurse training is the focus of 
attention. The curriculum could be expanded to include skills in identifying and 
managing depression and other mental disorders commonly affecting HIV-infected 
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patients, running support groups and mobilizing community awareness and participation 
in the social process of health. 
5.8 Conclusion 
The aim of this study was to estimate the prevalence of depression among people living 
with HIV/AIDS attending a primary health care centre in Kigali and to assess the factors 
that are associated with depression. From the findings of this study, it emerged that 
depression is high among people living with HIV who participated in the study. The 
majority of participants who scored positive to depression had mild to moderate 
depression and very few had severe depression. For all the socio-demographic factors and 
HIV medical related factors that were studied, it emerged from the findings of the study 
that being a female and lack of social support were statistically associated with scoring 
positive to depression. On the other hand, the number of HIV-related symptoms and 
having CD4 counts bellow 250 were statistically associated with scoring positive to 
depression. Although this was not assessed in this study, it was found that for all the 
respondents who made the sample size, only two were receiving treatment for mental 
disorders, which confirms the findings of Israelski et al. (2007) ; Petrushkin et al. (2005) 
that most of the time, depression is undetected and untreated in primary health care 
setting. 
The findings of this study underscore the importance of integrating mental health in 
HIV/AIDS services for appropriate mental health care of those affected. 
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Appendices 
Appendix 1: Data collection instruments 
Study Title: Exploring Depression among people living with HIV /AIDS 
Participant Number: Date: 
Instructions: There are three parts to this questionnaire. Part 1 asks you for some 
personal information about yourself, part 2 asks for your medical information and 
part 3 asks you to rate your mood. 
Please complete all three parts. 
Part 1: Demographic data 
Please answer each item. 
1. Please write in your age: 
2. Tick your gender: Male Q Female Q 
3. Please tick your relationship status: 
SingleO MarriecO DivorcedQ Separated^ CohabitingQ Widowl I 
4. Please tick your employment status: 
Employed Q Not emplovedl I 
5. Please tick the amount of money you and the people you live with use for 
your daily living: Less than 250 Frw/ dayQ More than 250 Frw/day Q 
6. Please tick who you live with: 
Family Q FriendsQ Live alonel I 
Please turn over 
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On a scale from 0 to 5, where 0 means extremely dissatisfied and 5 means 
extremely satisfied, please TICK how satisfied are you with the social 
support you receive from the following: 
Extremely dissatisfied Extremely satisfied 
4 • 
Level of satisfaction with social support 
1. How satisfied are you with the social support 
you receive from your family (husband, wife, 
children, siblings, relatives)? 
2. How satisfied are you with the social support 
you receive from your neighbors and friends? 
3. How satisfied are you with the social support 
you receive from your other social network (for 
example, your church, your work place)? 
4. How satisfied are you with the social support 
you receive from other people living with 
HIV/AIDS individually or in association? 
0 1 2 3 4 5 
Have you suffered from any psychiatric disorder or consulted a psychiatric 
service before you learnt of your HIV status? 
Yes • NoD 
If yes, what is the name of the psychiatric disorder? 
Do any of your immediate family members suffer or have suffered from a 
psychiatric disorder or consult a psychiatric service on a regular basis? 
Yes • NoD UnsureQ 
If yes, what is the name of the disorder they suffer from? 
Thank you for completing Part 1. Please turn over for part 2 about your medical 
status. 
I l l 
Participant Number: Date: 
Part 2: Medical Information 
10. Please write down the duration (months, years) you have known you are HTV 
positive: 
11. During the last month, how often have you been at the hospital for symptoms 
of HIV/AIDS? 
Never Q Once Q More than once Q 
12. During the last month, have you been admitted in the hospital for HTV 
symptoms? 
Yes • No D 
13. Which of the following symptoms related to HIV/ADDS have you had in the 
last month (or you still have)? 
13.1 No symptoms [~~| 
13.2 Unexplained weight loss I I 
13.3 Recurrent respiratory infection |~1 
13.4 Recurrent oral ulceration I I 
13.5 Unexplained chronic diarrhea Q 
13.6 Others • 
13.6.1 Please name or describe these other symptoms: 
14. The last time your blood was taken for testing, what range were you told 
your CD4 cells were in? Please write in the range you were given: 
Thank you for completing part two. Now please complete part three. 
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Participant Number: Date: 
PART THREE: INFORMATION ABOUT YOUR MOOD 
Directions: 
1. On this questionnaire are 21 groups of statements. 
2. Please read each group of statements carefully. 
3. Then pick the one statement in each group that best describes the way you have 
been feeling the past week, including today. 
4. Circle the number beside the statement you picked. 
5. Be sure to read all the statements in each group before making your choice. 
l.Mood 
2. Pessimism 
3. Sense of failure 
4. Lack of satisfaction 
5. Guilty feelings 
0 I do not feel sad. 
1 I feel sad. 
2 I am sad all the time and I can't snap out of it. 
3 I am so sad or unhappy that I can't stand it. 
0 I am not particularly discouraged about the future. 
1 I feel discouraged about the future. 
2 I feel I have nothing to look forward to. 
3 I feel that the future is hopeless and that things cannot 
improve. 
0 I do not feel like a failure. 
1 I feel I have failed more than the average person. 
2 As I look back on my life, all I can see is a lot of 
failures. 
3 I feel I am a complete failure as a person. 
0 I get as much satisfaction out of things as I used to. 
1 I don't enjoy things the way I used to. 
2 I don't get real satisfaction out of anything anymore. 
3 I am dissatisfied or bore with everything. 
0 I don't feel particularly guilty. 
1 I feel guilty a good part of the time. 
2 I feel guilty most of the time. 
3 I feel guilty all of the time. 
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12. Social withdrawal 
13. Indecisiveness 


































don't feel I am being punished, 
feel I may be punished, 
expect to be punished, 
feel I am being punished. 
don't feel disappointed in myself, 
am disappointed in myself, 
am disgusted in myself, 
hate myself. 
don't feel I am any worse than anybody else, 
am critical of myself for my weakness or mistakes. -
blame myself for my faults, 
blame myself for everything. 
don't have any thoughts of killing myself. 
have thoughts of killing myself but I would not carry 
them out. 
would like to kill myself, 
would like to kill myself if I had the chance. 
don't cry anymore than usual. 
cry now more than I used to. 
cry all the time now. 
used to be able to cry, but now I can't cry even though 
want to. 
am no more irritated than I ever am. 
get annoyed or irritated more easily than I used to. 
feel irritated all the time now. 
don't get irritated at all by the things that used to 
irritate me. 
have not lost interest in other people. 
am less interested in other people than I used to be. 
have lost most of interest in other people. 
have lost all of my interest in other people. 
make decisions about as well as I ever could, 
put off making decisions more than I used to. 
have greater difficulty in making decisions than 
before, 
can't make decisions at all anymore. 
don't feel any worse than I used to. 
am worried that I am looking old or unattractive. 
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15. Work inhibition 
16. Sleep disturbance 
2 I feel that there are permanent changes in my 
appearance that make me look unattractive. 
3 I believe I look ugly. 
0 I can work out as well as before. 
1 It takes extra effort to get started at doing something. 
2 I have to push myself very hard to do anything. 
3 I can't do any work at all. 
0 I can sleep as well as usual. 
1 I don't sleep as well as I used to. 
2 I wake up one or two hours earlier than usual and find 
it hard to get back to sleep. 
3 I wake up several hours earlier than I used to and 
cannot get back to sleep. 
17. Fatigability 
18. Loss of appetite 
19. Weight loss 
20. Somatic 
preoccupation 





















I don't get anymore tired than usual. 
I get tired more easily than I used to. 
I get tired from doing almost anything. 
I am too tired to do anything. 
My appetite is no worse than usual. 
My appetite is not as good as it used to be 
My appetite is much worse now. 
I have no appetite at all anymore. 
I haven't lost much weight, I any, lately. 
I have lost more than 5 pounds. 
I have lost more than 10 pounds. 
I have lost more than 15 pounds. 
I am no more worried about my health than usual. 
I am worried about physical problems such as aches 
and pains, or upset stomach, or constipation. 
I am very worried about physical problems and it is 
hard to think of much else. 
I am so worried about my physical problems that I 
cannot think about anything else. 
I have not noticed any recent change in my interest in 
sex. 
I am less interested in sex than I used to be. 
I am much less interested in sex now. 
I have lost interest in sex completely. 
(For researcher: Total score: 
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Appendix 1.2 Beck Depression Scale (Kinyarwanda version) 
IGIPIMO CY'AGAHINDA CYA BECK 
Numero y'usubiza: Itariki: 
Amabwiriza: 
1. Iki kiciro cy'ibibazo kigizwe n'ibice 21. Buri gice kigizwe n' interuro 4 
2. Soma neza buri gice na buri nteruro. 
3. Hitamo interuro muri buri gice isobanura neza uburyo wiyunvaga mu bijyanye 
n'amarangamutima yawe mu cyumweru gishize, kugeza uyu munsi. 
4. Zengurutsa akaziga ku mubare uri iruhande rw'interuro wahisemo. 




















Numva nta gahinda mfite 
Numva mfite agahinda 
Numva iteka mfite agahinda, birangora kuba nagasohokamo 
Mfite ishavu n'akababaro ntabasha kwihanganira 
Nunva ntahangayikishijwe by'umwihariko n'ubuzima buri imbere. 
Numva ubuzima buri imbere bunca intege. 
Nunva ntacyo nfite kimpa ikizere cy'ejo hazaza. 
Nunva ubuzima buri imbere nta kizere bumpa kandi nunva nta 
kintu nakimwe cyabihindura. 
Sinunva ko ntacyo nagezeho mu buzima bwanjye. 
Ntekereza ko ntacyo namaze mu buzima bwanjye mfatiye ku 
rugero rw'abandi bantu basanzwe. 
lyo nsubije amaso inyuma mu buzima bwanjye bwahise mbona 
bwararanzwe no kutagira icyo ngeraho. 
Nunva ndi umuntu udafite icyo amaze. 
Nunva nishimira ibintu uko byari bisansanzwe na mbere. 



















Nta kintu na kimwe kikinshjmisha habe na gato. 
Nunva ibintu byose bisigaye bitakinshimisha, bindambiye. 
Sinunva nishinja cyangwa nirega by'umwihariko. 
Hah igihe rimwe na rimwe nunva nishinja cyangwa nirega. 
Igihe kinini nunva hah ibyo nishinja cyangwa nirega. 
Igihe cyose hari ibyo nunva nishinja. 
Sinunva meze nk'uri mu gihano 
Nunva ah nkaho ndi mu gihano. 
Nunva meze nkutegereje guhanwa 
Nunva ndimo guhanwa. 
Nunva nfite agaciro muri njye. 
Nunva nta gaciro nfite muri njye. 
Nunva nihaze. 
























Sinunva ko merewe nabi cyane kuruta abandi bose. 
Mpora nigaya kubera intege nke zanjye cyangwa amakosa 
yanjye. 
Ndigaya kubera amakosa yanjye 
Nunva nishinja, nigaya kubera ibintu byose bimbaho. 
Ntabitekerezo nfite byo kuba nakwiyahura. 
Mfite ibitekerezo byo kwiyahura ariko nunva ntabishyira mu 
bikorwa 
Nunva nifuza kwiyahura. 
Nunva ndamutse mbonye uburyo nakwiyahura. 
Ntabwo nkirira cyane birenze uko nari nsanzwe 
Ndarira cyane muri iki gihe birengeje uko nari nsanzwe ndira. 
Ndarira buri munsi muri iki gihe. 
Kera najyaga mbasha kurira, ariko ubu simbibasha nubwo mba 
mbishaka. 
Sinkigira umunabi nkuko nawugiraga mbere. 
Nsigaye ndambirwa nkanagira umunabi kuburyo bworoshye 
kuruta uko nari meze mbere. 
Nsigaye nunva mporana umunabi igihe cyose. 
Singiterwa umunabi nibintu byawunteraga mbere. 
Sinigeze ntakaza gusabana nabandi bantu? 



































Natakaje ubushake nagiraga mu gusabana nabandi. 
Sinkigira na gato ubushake bwo gusabana nabandi. 
Mbasha gufata ibyemezo neza nkuko nari nsanzwe mbifata na 
mbere. 
Ntibinyorohera gufata ibyemezo nka mbere. 
Bisigaye bingora cyane gufata ibyemezo kuruta uko byari 
bimeze mbere. 
Sinkibasha gufata ibyemezo habe na gato. 
Sinunva mfite isura mbi kurusha mbere. 
Mfite ubwoba ko ngaragara nk'ushaje kandi utari mwiza ku 
mubiri 
Nunva hari impinduka zimbaho zituma ngenda nsa nabi ku isura 
Nunva nfite isura mbi kandi ngaragara nabi. 
Mbasha gukora nk'uko bisanzwe. 
Binsaba kongera imbaraga nyinshi kugirango mbashe gutangira 
kugira icyo nkora. 
Binsaba guhatiriza cyane kugirango mbashe kugira icyo nkora. 
Sinkibasha kugira icyo nkora na gito. 
Mbasha gusinzira neza nk'ibisanzwe. 
Sinsinzira neza nk'uko byari bisanzwe mbere. 
Nsigaye nicura isaha 1 cyangwa 2 mbere y'igihe nakangukiraga 
kandi bikangora kongera gusinzira. 
Nsigaye nicura amasaha menshi cyane mbere y'igihe 
nakangukiraga mbere kandi simbashe kongera gusinzira. 
Sinkinanirwa nk'uko nari nsanzwe nanirwa. 
Nsigaye nanirwa vuba cyane kuruta uko byari bimeze mbere. 
Nsigaye nanizwa n'ikintu cyose ngerageje gukora. 
Numva naniwe cyane kuburyo ntacyo nabasha gukora. 
Ntabwo nkibura apetit cyane nk'ibisanzwe. 
Apeti yanjye si nziza nkuko yahoze. 
Apeti yanjye yaragabanutse cyane muri iki gihe. 

















Ntabwo nataye ibilo byinshi mu minsi ishize. 
Nataye hejuru y'ibilo 2.5. 
Nataye hejuru y'ibilo 4.5. 
Nataye hejuru y'ibilo 6.5. 
Singihangayikishwa cyane n'ubuzima bwanjye nka mbere. 
Nunva mpangayikishijwe n'ibibazo by'umubiri: nko kuribwa, 
umutwe, kutamererwa neza mu gifu, cyangwa kunanirwa 
kwituma. 
Mpangayikishijwe cyane n'ibibazo by'umubiri kuburyo bingora 
kugira ikindi kintu ntekerezaho. 
Mpangayikishijwe bikabije cyane n'ibibazo by'umubiri kuburyo 
ntakindi mbasha gutekereza. 
Nta mpinduka nigeze ngira kubijyanye no kwifuza imibonano 
mpuzabitsina. 
Gushaka gukora imibonano mpuzabitsina byaragabanutse. 
Gushaka gukora imibonano mpuzabitsina byaragabanutse 
cyane. 
Singishaka nagato gukora imibonano mpuzabitsina. 
(Bireba umushakashatsi: Igiteranvo: 
Appendix 2: LETTERS OF PERMISSION TO CONDUCT RESEARCH 
Appendix 2.1 Letter of permission to Kimironko Health Centre 
The Management 
Kimironko Health Center, 
Kigali -Rwanda 
Dear Sir: 
Application to conduct a research at Kimironko Health Centre 
I hereby request permission to conduct research at Kimironko Health Centre. 
I am a student at the University of KwaZulu-Natal in the School of Nursing, undertaking 
a Master degree in Mental Health Nursing. One of the requirements for the degree is to 
conduct a research project. 
The title of the research is "Depression among people living with HIV/AIDS attending a 
Primary Health Care setting in Rwanda, a descriptive study". 
Kimironko Health Centre was purposively chosen to be the setting for this study. Data 
will be collected from 96 patients who are 18 years and older and living with HIV/AIDS 
and who attend the clinic for care. Patients will be required to complete two 
questionnaires and this will take place during their visit at the clinic. This protocol has 
been approved by the Research Ethics Committees of the University of KwaZulu-Natal, 
and of CNLS. These approvals are attached to this. Also attached is the informed consent 
for participants which shows that participation is voluntary and how the rights and 
identity of the patients will be protected in the research process. 
Your consideration will be greatly appreciated. 
Yours faithfully 
Benoite UMUBYEYI 
Research Supervisor: Dr. Lyn Middleton (University of KwaZulu-Natal) 
6th April, 2005 
120 
Appendix 2.2 Letter of request for application for approbation 




Application for approbation of a research proposal 
I hereby request the approbation of my research proposal by CNLS. 
I am a student at the University of KwaZulu-Natal in the School of Nursing, undertaking 
a Master degree in Mental Health Nursing. One of the requirements for the degree is to 
conduct a research project. 
The title of the research is "Exploring depression among people living with HIV/AIDS 
attending a Primary Health Care setting in Rwanda, a descriptive, cross-sectional 
study". 
Kimironko Health Centre was purposively chosen to be the setting for this study. Data 
will be collected from patients who are living with HIV/AIDS, aged 18 years and older 
and who attend the clinic for care. Participants will be required to complete two types of 
questionnaires and this will take place during their visit at the clinic. This protocol has 
been submitted to the Research Ethics Committee of the University of KwaZulu-Natal, 
and is waiting for approval. This letter will be forwarded to you as soon as it is available. 
The research protocol, the data collection tools and the consent form for participants are 
enclosed herein. The informed consent for participants shows that participation is 
voluntary and how the rights and identity of the patients will be protected in the research 
process. 
Your consideration will be greatly appreciated. 
Yours faithfully 
Benoite UMUBYEYI 
Research Supervisor: Dr. Lyn Middleton (University of KwaZulu-Natal) 
6m April, 2005 
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Appendix 3: Ethical Approval Letters 
Appendix 3.1: Letter of approval by CNLS 
PRESIDENCE DE LA REPUBLIQUE DU RWANDA Kigali, le 2 3 JUL '<•» 
COMMISSION NATIONALE DE LUTTE CONTRE LE SIDA 
B.P 7162 KIGALI 
N. R6f: .Q!>M?..../CNLS/2009/S.E 
V. Ref: 




Obiet: Approbation de votre Projet de recherche 
Madame, 
Suite a votre demande d'approbation du projet de recherche intitule «Exploring depression 
among people living with HIV/AIDS and attending a Primary Health Care Setting at 
Kigali, Rwanda: A descriptive study» adressee a la CNLS, j ' a i le piaisir de vous informer 
qu'apres lecture et analyse de votre protocole par le Comite de pilotage des recherches du 
domaine du VIH/SIDA, votre projet a ete approuve. 
A cet effet, la CNLS vous accorde rapprobation de votre projet et vous remercie pour Finteret 
que vous portez a la recherche dans le domaine du VTH/SIDA. 
Par ailleurs, il vous demande de bien vouloir partager avec le Comite de recherche dans le 
domaine du VIH/SIDA, les resultats de votre recherche. 
Veuillez agreer Madame, Fexpression de fetiche collaboration. 
Dr Anita ASHMWE 
Secretaire Executif 
CPI : 
- Ministre de la Sante 
- President du Comite national d'Btmque: 
COMMISSION NATIONALE DE LOTTE CONTRE LE SWA ( C.N.L.S ) 
Sis*: a Kigali -Rwanda ; e-mail.- cntsrgnuandol.com TeL . OQ 2SO 5039 SO ; Pax :+ SO 39 79 
Appendix 3.2: Letter of approval by the Research Ethics Committee of the 
University of KwaZulu-Natal 
RESEARCH OFFICE (GOVAN MBEKI CENTRE) 
WESTVILLE CAMPUS 




3 JULY 2009 
MS. U BENOITE (204501595) 
SCHOOL OF NURSING 
Dear Ms. Benoite 
ETHICAL CLEARANCE: "EXPLORING DEPRESSION AMONG PEOPLE LIVING WITH HIV/AIDS AND ATTENDING A 
PRIMARY HEALTH CARE SETTING IN KIGALI. RWANDA: A DESCRIPTIVE STUDY: 
I wish to confirm that ethical clearance has been granted for the above project, subject to necessary gatekeeper permission being 
obtained: 
This approval is granted provisionally and the final clearance for this project will be given once the above conditions 
have been met. Your Ethical Clearance Number is HSS/0369/09 
Kindly forward your response to the undersigned as soon as possible 
Yours faithfully 
MS. PHUMELELE XIMBA 
ADMINISTRATOR 
HUMANITIES & SOCIAL SCIENCES ETHICS COMMITTEE 
cc. Supervisor (Dr. L Middieton) 
cc. Mr.SReddy 
Appendix 3.3: Letter of Permission to conduct research at Kimironko health care 
centre 
REPUBLIQUE DU RWANDA 
MINISTERE DE LA SANTE 
CENTRE DE SANTE KIMIRONKO 
Object: Permission de conduire le projet de recherche. 
Kigali le 05/07/09 
Madame Umubyeyi Benoite 
Kigali Health Institute. 
Kigali. 
Madame, 
Suite a votre demande de permission de 
conduire votre projet de recherche intitule « Exploring depression among people living with HIV/AIDS 
and attending a Primary Health Care Setting: A descriptive study », au sein du centre de sante 
KIMIRONKO, j 'a i le plaisir de vous informer que la permission yous est accordee. 
Nous vous prions de bien vouloir 
respecter les conditions d'ethique et de ne commencer la collecte des donnees qu'apres approbation de 
votre projet de recherche par le comite de pilotage des recherches de la CNLS. Vous avez aussi recue la 
permission de consulter les dossiers des patients dans le cadre de votre recherche. 
Par ailleurs, il vous est demande de bien 
vouloir partager avec le centre de sante les resultats de votre recherche. 
Nous vous remercions d'avoir choisi le 
centre de sante Kimironko pour faire le terrain de votre recherche. 
Veuillez agreer Madame, 1'expression de notre tranche collaboration 
iJ: 
nnva Jean Pierre; 
* * 5 " % :- ' * - • ' • / , • . . • X? 
'***'• % ''•'•• ; ' - ' • - " ' V •** '^ 
TitulairecleC.S Kiniiron 
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Appendix 4: Patients information document and declaration of 
consent to participate 
Dear Participants, 
My name is Benoite UMUBYEYI; I am a student at the University of KwaZulu-Natal, 
undertaking a Masters degree in Mental Health Nursing. One of the requirements for the 
degree is to conduct a research project. 
This letter serves to ask consent from you to take part in this research. The purpose of the 
research is to understand the feeling of depression that some people living with HIV gave 
from time to time. This will help to understand the importance of the problem of 
depression, which is sometimes under-looked in the care of people living with 
HIV/AIDS. Depression is a very painful and unpleasant experience but the symptoms can 
be managed. This study will help us to know how many people do suffer from depression 
so that the clinic can help them to manage it. 
You are thereby requested to answer a questionnaire with three parts. The first part asks 
you for personal information about yourself, the second for medical information and the 
third to describe how you have been feeling in the last two weeks. All this information 
will be kept confidential. No names will be asked for and only the researcher and her 
lecturer will have access to the questionnaires. The questionnaires will be destroyed after 
the study is complete. 
Your participation in this research is voluntary. If you decide not to participate there will 
be no negative consequences for you. If you do decide to participate there will be no 
benefits for you. However, if you report feeling very depressed or have thoughts of 
harming yourself or others the researcher will, with your permission, be able to refer you 
immediately to a person at the clinic for assistance. 
It will take you approximately 20 minutes of your time to complete the questionnaire. 
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Contact Details 
1. Contact details of researcher (for further information / reporting of study 
related adverse events). 
Benoite UMUBYEYI 
University of KwaZulu-Natal 
School of Nursing 
Tel: 0798305760 
2. Contact details of the research ethic committee of Kigali Health Institute (for 
reporting of complaints / problems). 
Dr Kato Ndjunwa 
Kigali Health Institute 
Faculty of Allied sciences 
Office Tel:(+250) 572172 
3. Contact details of the research supervisor (for further information on the 
research and reporting of study related adverse events). 
Dr. Lyn Middleton 
School of Nursing 
5th Floor Desmond Clarence Building 
Howard College Campus 
Faculty of Health Sciences 
University of KwaZulu-Natal 
DURBAN 
South Africa 
Tel: +27 31260 1655 
Fax:+27 31 260 2855 
Thank you for your decision to take part in this research. 
Yours truly, 
Benoite UMUBYEYI 
Research Supervisor: Dr. Lyn Middleton 
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DECLARATION OF CONSENT TO PARTICIPATE IN THE RESEARCH 
I hereby confirm that I understand the contents of this document and the nature of the 
research project, and I consent to participating voluntarily in the research project. 
I understand that I am at liberty to withdraw from the project at any time, should I so 
desire. 
SIGNATURE OF PARTICIPANT DATE 
Appendix 5: Tables of variables 
Appendix 5.1. Summary of variables, instruments and analyses used in HIV/AIDS and psychiatric disorder prevalence studies 
Title of the study 
1. Psychiatric disorders 
among HIV-positive 
population in 
Nigeria: a control 
study 




3. Symptoms of 
depression and 
anxiety among a 
sample of South 
African patients 











1. Present and past psychiatric disorders 
2. Sociodemographic data e.g. age, gender, 
marital status, educational level, 
socioeconomic status and level of social 
support 
3. Clinical details (stage of the disease, time 
of diagnosis, any present medical 
problems, previous hospital admissions 
due to HIV, and length of ARVs use) 
1. Rate, severity and types of depressive 
symptoms 
2. Adherence to HAART, CD4 and viral 
load 
3. Sociodemographic variables e.g. gender, 
ethnic group, alcohol and substance 
abuse 
1. Psychological distress 
2. Symptoms of depression 
3. Symptoms of anxiety 
Measurement instruments used 
1. Mini International Neuropsychiatry 
Interview 
2. Proforma questionnaire about 
sociodemographic data 
3. Licket scale measure for social 
support 
4. Clinical information from clients 
1. Structured clinical interview for DSM 
IV 
2. Beck Depressive Inventory (2nd 
edition) 
3. Medication adherence questionnaire 
1. The Hopkins Symptoms Checklist 
(HSCL-25) to measure psychological 
distress 
2. Beck Depression Inventory Scale 
Type of Analyses performed 
1. Frequencies, mean and standard 
deviation 
2. Chi-square and Student's / test 
1. Frequency statistics 
2. Correlation between depressive 
symptoms & severity and adherence 
3. Depressive symptoms correlated with 
demographic variables 
4. ANOVA used to compare gender and 
ethnic group on depressive severity 
and subtypes of depression symptoms 
1. SPSS version 14 
2. Descriptive statistic; sample mean and 
standard deviation 
3. T-test used to establish significance 
difference between variables 
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4. Depression in people 
living with 
HIV/AIDS attending 
primary care and 
outpatients clinics 
5. Depressive and 
anxiety disorders in 
women with HIV 
infection 
Komiti et al. 
(2003) 
Morrison et al. 
(2002) 
1. Demographic data (employment status; 
living situation and relationship status) 
2. Medical information (CD4 cell counts; 
Viral load; ART and HIV related 
medication; stage of illness and duration 
of known HIV seropositivity) 
3. Psychiatric data (current psychiatric 
diagnosis by the treating practitioner; 
treatment; treatment provider; past 
psychiatric diagnosis; alcohol and illicit 
drug use) 
4. Symptoms of depression 
1. Depressive symptoms scores 
2. Anxiety symptoms scores 
3. Physical, neuro-psychological and 
immune aspects of HIV infection 
4. Sociodemographic data (age; race; 
marital status; number of children; and 
monthly income) 
5. HIV disease stage and ART 
1. Questionnaire to collect medical data 
and psychiatric data 
2. Questionnaire to collect 
sociodemographic information and 
drug/alcohol use 
3. The Inventory to Diagnose 
Depression(IDD) 
4. Laboratory tests (Quantiplex RNA 
assay; COBAS Amplicor HIV monitor 
assay) 
1. Interviews: physical and 
neuropsychological examination 
2. Questionnaires assessing mood, 
psychosocial factors, health habits 
3. 17- items Hamilton Depression Rating 
Scale 
4. Classification of HIV disease status 
used Centre for Disease Control and 
Prevention (CDC) criteria for staging 
of HIV infection 
1. Non-parametric methods to compare 
those who met criteria for depression 
and those who did not 
2. Continuous variables compared using 
Kruskal-Wallis Test 
3. Categorical variables compared using 
Chi-square test 
1. SAS version 8.01 
2. Univariate test and estimation of odds 
ratios for discrete variables 
3. Kruskal-Wallis Test was performed to 
compare p value for seronegative 
versus seropositive and constant 
variance assumptions. 
4. ANOVA was used for continuous 
variables of Hamilton depression and 
anxiety scale scores 
Table 1: Continued 





care for HIV/AIDS 
7. Purpose in Life and 
Depressive 
symptoms in persons 
Author and 
Date 





1. Demographic data (gender; age; 
ethnicity) 
2. Medical information (AIDS status; use of 
ARTs; CD4 counts and viral load) 
3. Utilization of psychiatric and social 
service 
4. Symptoms of depression, PTSD and 
acute stress disorders 
1. Demographic data (age; ethnicity; 
gender) 
2. Concurrent medications both ART and 
Measurement instruments used 
1. Structured questionnaire to collect 
demographic data 
2. Patients record for medical information 
3. Beck Depression Inventory 
4. Posttraumatic Stress Checklist-Civilian 
(PCL-C) 
5. The Stanford Acute Stress Reaction 
Questionnaire (S ASRQ) 
1. Self-administered questionnaire 
2. Sociodemographic tool 
3. The Center for Epidemiological 
Type of analyses performed 
1. Descriptive statistical methods, 
frequency description and percentages 
2. Central tendencies (mean, median and 
standard deviation) were used for 
continuous data (age, viral load, CD4 
results). 
3. In cross-tabulation analysis, Mantel-
Haentzel odds ratios were calculated 
using SPSS 13.0 
4. Multivariate logistic regression were 
used to estimate the relative 
association between demographic with 
symptom criteria 
1. Inferential statistics e.g multiple 
regression 
2. Hierarchical regression analysis was 
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living with HIV 
disease 




HIV/AIDS: 2 years 
follow-up 
Gibbie et al. 
(2006) 
antidepressants 
3. Frequency of depressive symptoms 
4. Purpose in life 
5. Severity of HI V disease (CD4+ T 
lymphocytes) 
1. Depression 
2. HIV illness progression (CD4, viral load) 
3. Demographic data (age; education; 
current living situation; current 
relationship status; current and past 
alcohol and illicit drug; and personal 
psychiatric history) 
Studies Depression Scale (CES-D) 
4. Purpose in Life Scale 
5. Revised HIV Center Medical Staging 
Scale (r-HCMSS) 
6. Clinical support laboratory used to 
measure CD4+ 
7. Reverse Transcription Polymerase 
Chain Reaction (RT-PCR) 
1. Beck Depression Inventory Scale 
2. Structured Clinical Interview for 
Depression (SCID-CV) 
3. Neuropsychological tests (Cambridge 
Neuropsychological Test Automated 
Battery (CANTAB) and the Hopkins 
HIV dementia Scale (HDS)) 
4. Laboratory assays for CD4 counts, 
viral load 
5. HIV symptoms and AIDS defining 
illness were obtained from patient 
record 
used to test the hypothesis that the 
purpose in life is a stronger predictor 
of depressive symptoms. 
3. Hierarchical multiple regression model 
was constructed in which demographic 
variables and then HIV disease 
severity indicators were compared to 
depressive symptoms. 
1. SPSS version 10 
2. Univariate analysis using %2 for 
categorical variables 
3. Kruskal-Wallis Test for continuous 
variables 
4. Multiple linear regression model used 
to measure association 
Table 1: Continued 
Title of the study 
9. Symptoms of 
depression and 
anxiety among a 
sample of South 
African patients 
living with a chronic 
illness 
10. Nature of depression 





Judd et al. 
(2005) 
Variables studied 
1. Psychological distress 
2. Symptoms of depression 
3. Symptoms of anxiety 
1. Sociodemographic data (gender; age; 
employment; educational level; 
sickness/disability pension; intimate 
relationship) 
2. Medical characteristics (HIV-RNA loads; 
CD4 cell counts, duration of knowing 
HIY diagnosis) 
3. Personality traits 
4. Illicit substance use 
5. Medical adherence 
6. Cognitive impairment 
Measurement instruments used 
1. The Hopkins Symptoms Checklist 
(HSCL-25) to measure psychological 
distress 
2. Beck Depression Inventory Scale 
1. Beck Depression Inventory 
2. Revised Neo Personality Inventory 
3. Structured Clinical Interview for DSM 
4. The Hopkins HIV dementia scale 
5. The Grooved Peg-board and the 
Cambridge Automated 
Neuropsychological Test Battery 
Type of analyses performed 
1. SPSS version 14 
2. Descriptive statistic 
3. T-test used to establish significance 
difference between variables 
1. Descriptive analysis 
2. Correlation 
3. Chi-square test 
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11. Factors associated 
with depression 
among homeless and 
marginally housed-
HIV infected men in 
San Francisco 
Weiser et al. 
(2006) 
1. Symptoms of depression 
2. Sociodemographic characteristics e.g. 
age, race, sex, income, education, 
homelessness and representative payee. 
3. Drug and alcohol use 




Beck Depression Inventory Scale 
Structured interviews 
Blood for CD4 and viral loads 
1. SAS statistical analysis software, 
version 8 
2. Multiple logistic regression used to 
measure association 
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_Appendix 5.2 Summary of this study design, the variables under study, the instruments to measure the variables and type 
of analysis. 
Title of the study 
Depression among people living with 
HIV/AIDS and attending a primary 





Variables to be studied 
Increased biological vulnerability (HIV 
related medical information ): 
" CD4 cell 
• HIV/AIDS related symptoms 
• Time known of HIV positive status 
Decreased social and personal protective 
factors (Sociodemographic factors): 
* Age 
• Gender 
• Marital status 
• Social support 
• Employment 
• Socio-economic status 
• History of a psychiatric disorder 
Depressive symptoms in BDI 
• 0-9 score: Normal range 
• 10-18 score: Mild- Moderate 
• 19-29 score: Moderate-severe 
• 30-63 score: severe 










Type of Analysis 
-Descriptive statistic analysis: 
frequencies, mean, standard 
deviation 
-The categorical variables in 
this study were compared for 
correlation with depressive 
symptoms using the Chi-
square test-
-To analyze the extent to 
which numerical variables are 
associated with depressive 
symptoms; the /-test for 
independent sample test was 
used. 
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